Asian Journal of Biochemical and Pharmaceutical Research Recent Advances on the Synthesis of Pyrazole-Containing Compounds of Potent Biological Activities and Study Their Chemical Applications
Preparation of pyrimido[4,5 b][1,6]naphthyridin-4(1 h)-one derivativeselshimaa eid
This document describes the preparation of pyrimido[4,5-b][1,6]naphthyridin-4(1H)-one derivatives using a zeolite-nanogold catalyst. An efficient one-pot synthesis is developed involving the cyclocondensation of 6-amino-2-thioxo-2,3-dihydropyrimidin-4(1H)-one, aromatic aldehydes, and 1-benzylpiperidin-4-one in ethanol at 80°C. The nanogold catalyst is characterized and found to contain 4-6 nm gold nanoparticles dispersed on zeolite. Several derivatives are synthesized in good yields and characterized. Molecular dock
The document summarizes 5 research studies conducted by B. V. Subba Reddy and colleagues on the synthesis of various heterocyclic compounds using transition metal catalyzed reactions of diazoketones and related substrates:
1. Synthesis of 2,3-disubstituted indoles and 2,4,5-trisubstituted pyrroles from α-diazoketones using Cu(OTf)2 catalysis. Application to the synthesis of the natural product Homofascaplysin C.
2. Acetal-initiated Prins bicyclization for the synthesis of furo[3,4-c]furan lignans and pyrano[3
A new and efficient synthesis of 1 (4-subtitued phenyl)-3-(1-(6-(substitued-2...Alexander Decker
This document describes a new efficient method for the synthesis of 1-(4-Subtitued phenyl)-3-(1-(6-(Substitued-2-yl)pyrimidin-4-yl)piperidin-4-yl)ureas. Tert-butyl (1-(6-chloropyrimidin-4-yl)piperidin-4-yl)carbamate is coupled with various arylboronic acids using Suzuki coupling to yield intermediates. These intermediates are then deprotected and coupled with various aryl isocyanates using triethylamine to yield the final urea products in good yields. In total, twelve new 4,6-disubstituted
Pyrimidine derivatives have attracted attention due to their presence in biological systems and prominent pharmacological activity. This document discusses the synthesis, structure, and biological activities of various pyrimidine analogues. Specifically, it details methods for synthesizing pyrimidine analogues through Biginelli reactions and microwave-assisted reactions. It then evaluates the antimicrobial, antitubercular, anti-inflammatory, antioxidant, anticonvulsant, anticancer, and analgesic activities of different pyrimidine derivatives through in vitro assays. Several analogues demonstrated high inhibition of microbial growth or potent activity against conditions like tuberculosis, seizures, and cancer.
Novel coumarin isoxazoline derivatives: Synthesis and study of antibacterial ...Ratnakaram Venkata Nadh
A highly efficient and mild protocol for the syntheses of ethyl-3-
[7-benzyloxy-4-methyl-2-oxo-2H-8-chromenyl]-5-aryl-4,5-dihydro-4-
isoxazole carboxylates and ethyl-3-[7-benzyloxy-3-chloro-4-methyl-2-
oxo-2H-8-chromenyl]-5-aryl-4,5-dihydro-4-isoxazole carboxylates in
good yields via [3 þ 2] cycloaddition of in situ–generated nitrile
oxides from 7-benzyloxy-4-methyl-coumarin hydroxymoylchlorides
and 7-benzyloxy-3-chloro-4-methyl-coumarin hydroxymoylchlorides
respectively with ethyl-3-aryl prop-2-enoate has been developed.
The new compounds are screened for antibacterial activity.
Copper catalyzed synthesis of N-Heterocycles containing one M-atomssusercbfc01
This document summarizes copper-catalyzed methods for synthesizing various N-heterocycles containing one nitrogen atom. It discusses the synthesis of pyrrole, pyrrolidine, indole, and indolone derivatives using copper catalysts under mild conditions. Various studies are reviewed that achieve these syntheses with good yields and functional group tolerance. Copper catalysts offer advantages over other metals like palladium in providing cost-effective routes for producing valuable pharmaceutical compounds. Future work may focus on developing more sustainable and efficient copper-catalyzed methods.
This document describes a novel protocol for the construction of 3-spiropyrrolidines and 3-spiropyrrolizidines using Baylis-Hillman adducts derived from nitroolefins via 1,3-dipolar cycloaddition reaction. Specifically, it details the successful synthesis of compound 3, a 3-spiropyrrolidine, from the Baylis-Hillman adduct 2 treated with isatin and N-methyl glycine. The compound was characterized through various analytical techniques and obtained in 62% yield. This reaction demonstrates the utility of Baylis-Hillman adducts from nitroolefins in azomethine ylide-based cycloaddition to form nitrogen-containing
Novel approach to synthesis of pentofurano nucleoside assisted natural phosph...Alexander Decker
This document describes a novel method for synthesizing various ribonucleosides using natural phosphate doped with CF3SO3H (NP/CF3SO3H) as a catalyst. Several ribonucleosides were prepared from 1-O-acetyl-2,3,5-tri-O-benzoyl-β-D-ribofuranoside and silylated nucleobases under mild conditions using NP/CF3SO3H. The reaction proceeded through an oxonium intermediate to provide the desired nucleosides in good yields ranging from 20-35%. The method was found to be regioselective, stereoselective, simple, efficient and environmentally friendly for synthesizing various D
Preparation of pyrimido[4,5 b][1,6]naphthyridin-4(1 h)-one derivativeselshimaa eid
This document describes the preparation of pyrimido[4,5-b][1,6]naphthyridin-4(1H)-one derivatives using a zeolite-nanogold catalyst. An efficient one-pot synthesis is developed involving the cyclocondensation of 6-amino-2-thioxo-2,3-dihydropyrimidin-4(1H)-one, aromatic aldehydes, and 1-benzylpiperidin-4-one in ethanol at 80°C. The nanogold catalyst is characterized and found to contain 4-6 nm gold nanoparticles dispersed on zeolite. Several derivatives are synthesized in good yields and characterized. Molecular dock
The document summarizes 5 research studies conducted by B. V. Subba Reddy and colleagues on the synthesis of various heterocyclic compounds using transition metal catalyzed reactions of diazoketones and related substrates:
1. Synthesis of 2,3-disubstituted indoles and 2,4,5-trisubstituted pyrroles from α-diazoketones using Cu(OTf)2 catalysis. Application to the synthesis of the natural product Homofascaplysin C.
2. Acetal-initiated Prins bicyclization for the synthesis of furo[3,4-c]furan lignans and pyrano[3
A new and efficient synthesis of 1 (4-subtitued phenyl)-3-(1-(6-(substitued-2...Alexander Decker
This document describes a new efficient method for the synthesis of 1-(4-Subtitued phenyl)-3-(1-(6-(Substitued-2-yl)pyrimidin-4-yl)piperidin-4-yl)ureas. Tert-butyl (1-(6-chloropyrimidin-4-yl)piperidin-4-yl)carbamate is coupled with various arylboronic acids using Suzuki coupling to yield intermediates. These intermediates are then deprotected and coupled with various aryl isocyanates using triethylamine to yield the final urea products in good yields. In total, twelve new 4,6-disubstituted
Pyrimidine derivatives have attracted attention due to their presence in biological systems and prominent pharmacological activity. This document discusses the synthesis, structure, and biological activities of various pyrimidine analogues. Specifically, it details methods for synthesizing pyrimidine analogues through Biginelli reactions and microwave-assisted reactions. It then evaluates the antimicrobial, antitubercular, anti-inflammatory, antioxidant, anticonvulsant, anticancer, and analgesic activities of different pyrimidine derivatives through in vitro assays. Several analogues demonstrated high inhibition of microbial growth or potent activity against conditions like tuberculosis, seizures, and cancer.
Novel coumarin isoxazoline derivatives: Synthesis and study of antibacterial ...Ratnakaram Venkata Nadh
A highly efficient and mild protocol for the syntheses of ethyl-3-
[7-benzyloxy-4-methyl-2-oxo-2H-8-chromenyl]-5-aryl-4,5-dihydro-4-
isoxazole carboxylates and ethyl-3-[7-benzyloxy-3-chloro-4-methyl-2-
oxo-2H-8-chromenyl]-5-aryl-4,5-dihydro-4-isoxazole carboxylates in
good yields via [3 þ 2] cycloaddition of in situ–generated nitrile
oxides from 7-benzyloxy-4-methyl-coumarin hydroxymoylchlorides
and 7-benzyloxy-3-chloro-4-methyl-coumarin hydroxymoylchlorides
respectively with ethyl-3-aryl prop-2-enoate has been developed.
The new compounds are screened for antibacterial activity.
Copper catalyzed synthesis of N-Heterocycles containing one M-atomssusercbfc01
This document summarizes copper-catalyzed methods for synthesizing various N-heterocycles containing one nitrogen atom. It discusses the synthesis of pyrrole, pyrrolidine, indole, and indolone derivatives using copper catalysts under mild conditions. Various studies are reviewed that achieve these syntheses with good yields and functional group tolerance. Copper catalysts offer advantages over other metals like palladium in providing cost-effective routes for producing valuable pharmaceutical compounds. Future work may focus on developing more sustainable and efficient copper-catalyzed methods.
This document describes a novel protocol for the construction of 3-spiropyrrolidines and 3-spiropyrrolizidines using Baylis-Hillman adducts derived from nitroolefins via 1,3-dipolar cycloaddition reaction. Specifically, it details the successful synthesis of compound 3, a 3-spiropyrrolidine, from the Baylis-Hillman adduct 2 treated with isatin and N-methyl glycine. The compound was characterized through various analytical techniques and obtained in 62% yield. This reaction demonstrates the utility of Baylis-Hillman adducts from nitroolefins in azomethine ylide-based cycloaddition to form nitrogen-containing
Novel approach to synthesis of pentofurano nucleoside assisted natural phosph...Alexander Decker
This document describes a novel method for synthesizing various ribonucleosides using natural phosphate doped with CF3SO3H (NP/CF3SO3H) as a catalyst. Several ribonucleosides were prepared from 1-O-acetyl-2,3,5-tri-O-benzoyl-β-D-ribofuranoside and silylated nucleobases under mild conditions using NP/CF3SO3H. The reaction proceeded through an oxonium intermediate to provide the desired nucleosides in good yields ranging from 20-35%. The method was found to be regioselective, stereoselective, simple, efficient and environmentally friendly for synthesizing various D
Synthesis, Characterization and Biological evaluation of substituted Pyrazole...SriramNagarajan15
The work presented in this article consists of synthesis, characterization and biological evaluation of substituted pyrazole derivatives. Pyrazole derivatives have been shown to have wide variety of pharmacological activities like antimicrobial, antiviral, antihistaminic, antitumor, antipyretic, anti-inflammatory, antidepressant and anticonvulsant. As combination of biologically active moieties into one molecule and synthesis of totally newer moieties have been the methods of research, we present here synthesis of some novel pyrazole derivatives incorporating various biologically active aryl/aryloxy acid derivatives such as ibuprofen, diclofenac, aceclofenac as well as potent antibacterial quinolones, norfloxacin and ciprofloxacin. All the compounds synthesized were evaluated for their antimicrobial activity.
This document summarizes a study on the synthesis of bromo and chloro derivatives of Baylis–Hillman adducts derived from nitroolefins. The researchers developed a simple protocol to synthesize these derivatives in good yields. They treated Baylis–Hillman adducts derived from nitroolefins with hydrobromic acid or iron chloride to obtain the bromo or chloro derivatives. The derivatives were characterized using NMR, IR and mass spectrometry. The novel bromo and chloro derivatives were shown to have potential as building blocks for a wide variety of organic compounds.
Sodium Hypophosphite An Efficient Catalyst for the Synthesis of 2 Substituted...ijtsrd
The preparation of one pot three components synthesis of 2 substituted Benzimidazole derivatives using reactants aldehyde o phenylenediamines and sodium hypophosphite as catalysis in solvent medium. Reaction is carried out at 800C for 1 to 2 hour gives high yield. Amit P. Tayade | Ramkrushna P. Pawar "Sodium Hypophosphite: An Efficient Catalyst for the Synthesis of 2-Substituted Benzimidazole" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-4 | Issue-3 , April 2020, URL: https://www.ijtsrd.com/papers/ijtsrd30622.pdf Paper Url :https://www.ijtsrd.com/chemistry/other/30622/sodium-hypophosphite-an-efficient-catalyst-for-the-synthesis-of-2substituted-benzimidazole/amit-p-tayade
IJERA (International journal of Engineering Research and Applications) is International online, ... peer reviewed journal. For more detail or submit your article, please visit www.ijera.com
Synthesis and Characterization of 3, 5-Diaryl-4-Benzoyl-1- Pyridoyl-Δ 2 - Pyr...IOSR Journals
This document summarizes the synthesis and characterization of 3,5-diaryl-4-benzoyl-1-pyridoyl-Δ2- pyrazolines. It describes the reaction of isoniazid with 3-aroyl flavanones in pyridine medium to synthesize these compounds. The structures of the synthesized compounds were established using spectral analysis and elemental analysis. Six compounds were successfully synthesized and their physical characterization data including melting points and molecular formulas are presented in Tables 1 and 2. The major advantage of this synthesis method is the ease of workup. These pyrazoline derivatives are reported to have various biological activities including antitubercular and antimicrobial properties.
This document summarizes the synthesis of new C-2, C-3 substituted heterocyclic derivatives of L-ascorbic acid and their characterization and evaluation of bacterial activity. Specifically, it describes the multi-step synthesis of Schiff bases and 1,3-oxazepine derivatives from L-ascorbic acid, including protection of hydroxyl groups, esterification, hydrazide formation, Schiff base formation with substituted benzaldehydes, and Diels-Alder reaction with phthalic anhydride to form 1,3-oxazepines. The synthesized compounds were characterized using melting point, FTIR, and 1H NMR spectroscopy and tested for antibacterial activity against gram-positive and
This document reviews recent developments in the diversity-oriented synthesis of heterocycles using multi-component reactions (MCRs). It provides examples of MCRs that construct 3 to 7-membered heterocyclic rings containing 1 to 4 heteroatoms of N, O, or S. The examples demonstrate how MCR conditions have improved over time, with reactions now occurring at room temperature rather than 360°C, in minutes rather than hours, and yielding products in nearly quantitative amounts. A variety of heterocycles can be synthesized through these efficient MCR approaches, including aziridines, azetidines, pyrroles, pyrrolidines, furans, indoles, pyrazoles, im
A series of novel 5-[2-(4-fluorobenzyl)-6-aryl-imidazo[2,1-b][1,3,4]thiadiazol-5-ylmethylene] thiazolidine-2,4-dione derivatives (4a-d) were synthesized. These final compounds (4a-d) were synthesized by Knoevenagel condensation of 2-(4-fluorobenzyl)-6-arylimidazo[2,1-b][1,3,4]thiadiazole-5-carbaldehydes (3a-d) with thiazolidine-2,4-dione. All the newly synthesized compounds were screened for their invivo hypoglycemic and hypolipidemic activity in male Wister rats. The Structures of all the newly synthesized compounds were established by analytical and spectral data.
Study of the Synthesis of Pyrrole and its Derivativesijtsrd
The article presents the theoretical studies results of hydraulic shock with flow continuity rupture in the pressure the pumping station pipeline. Calculated dependencies are obtained for calculating the shock pressure magnitude and the first period duration of reduced pressure, taking into account the hydraulic resistance along the pipeline length in the discontinuity event in the flow. The calculation results are compared with the Professor D.N. Smirnov"-™s experiments results.Comparative calculations using the proposed method with D.N. Smirnov experimental data gives a satisfactory agreement and confirms the proposed method reliability. Safarov Megli Djumayevich | Nazarov Asror Allanazarovich "Study of the Synthesis of Pyrrole and its Derivatives" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Special Issue | Modern Trends in Scientific Research and Development, Case of Asia , October 2020, URL: https://www.ijtsrd.com/papers/ijtsrd37971.pdf Paper Url :https://www.ijtsrd.com/economics/other/37971/study-of-the-synthesis-of-pyrrole-and-its-derivatives/safarov-megli-djumayevich
The document discusses various methods for synthesizing pyrazoles, including the Knorr pyrazole synthesis, reactions involving α,β-unsaturated aldehydes, β-hydroxy ketones, aromatic aldehydes, vinyl ketones, and more. It also covers pharmacological activities of pyrazoles such as antibacterial, antifungal, anticancer, anti-inflammatory, and anti-viral properties. Specific compounds are mentioned that have shown effectiveness against various bacterial, fungal, and viral strains. A wide range of synthetic routes and biological activities of pyrazoles and their derivatives are presented.
Synthesis and Characterization of Some Pyrazole Based Heterocyclic Compoundsijtsrd
This document summarizes a research article about the synthesis and characterization of pyrazole-based heterocyclic compounds. The article describes the synthesis of several pyrazole derivatives through multiple reaction steps starting from common organic compounds. The synthesized compounds were characterized using techniques like IR, NMR, and mass spectroscopy. Some of the compounds were found to have antimicrobial activity. In general, the document discusses the synthesis of novel pyrazole derivatives and characterization of their structures.
This document reviews 3,4-dihydropyrimidines thione, their chemistry and pharmacological potentials. It begins with background on pyrimidine structures and properties. It then discusses the chemical properties of pyrimidines and derivatives, including electrophilic and nucleophilic reactions. Biological importance is explained by pyrimidine's presence in nucleic acids, vitamins, and other biologically active compounds. Dihydropyrimidines are introduced as compounds obtained from cyclocondensation reactions. Several studies evaluating dihydropyrimidines as calcium channel blockers, antihypertensives, antibacterials, antifungals, and antioxidants are summarized.
This document describes the synthesis of novel spirooxindole derivatives via a three-component 1,3-dipolar cycloaddition reaction. Various spirooxindole-spiropiperidinone-pyrrolidine and spirooxindole-spiropiperidinone-pyrrolizine derivatives were synthesized in good yields from isatin, sarcosine or L-proline, and Knoevenagel adducts under optimized reaction conditions. The antimicrobial activities of the synthesized compounds were evaluated, with some compounds exhibiting excellent activity against bacteria and fungi, comparable or superior to standard antimicrobial drugs.
This document describes a one-pot synthesis of 3,4-dihydropyrimidin-2(1H)-ones and thiones using 4-nitrophthalic acid as a catalyst under solvent-free conditions. Various aldehydes, 1,3-dicarbonyl compounds, and urea or thiourea reacted smoothly in good to excellent yields. The reaction conditions were optimized to use a 2 mol% catalyst loading at 90°C for 30 minutes. 4-Nitrophthalic acid proved to be an effective and inexpensive catalyst for this Biginelli reaction, providing advantages over other reported catalysts such as higher yields, simpler workup, and an environmentally friendly procedure. The products were characterized
A Study of Synthesis and Characterization of Liquid Crystalline Substancesijtsrd
Synthesis of homologous series is achieved and having favourable geometry for the formation of mesophase along with formation of nano sized liquid crystal having good stability with metal free formulation which may be utilized further for the industrial application. The formation of liquid crystal with help of homologous series synthesized and characterization showed it to be metal free liquid crystal made up of oil, surfactant and co surfactant mixture which may open doors of nano gels, gels or microemulsion for liquid crystal. This along with texture study and magnetic study shows that unique properties were characterized and showed that metal free formation of liquid crystals with very less particle size and very good particle stability. M. H. Shah | D. K. Bhoi | M. B. Chauhan | N. B. Patel "A Study of Synthesis and Characterization of Liquid Crystalline Substances" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-6 | Issue-6 , October 2022, URL: https://www.ijtsrd.com/papers/ijtsrd51848.pdf Paper URL: https://www.ijtsrd.com/physics/other/51848/a-study-of-synthesis-and-characterization-of-liquid-crystalline-substances/m-h-shah
Synthesis of 1,5 Benzodiazepines A ReviewYogeshIJTSRD
Benzodiazepines are bicyclic heterocycles having medicinal importance. As a result several greener procedures have been developed using mild conditions and recyclable catalysts, easy work up good yields, multi component reactions less wastage and solvent less synthesis. Deepali Mahajan | Abhishek Raina "Synthesis of 1,5- Benzodiazepines: A Review" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-5 , August 2021, URL: https://www.ijtsrd.com/papers/ijtsrd43842.pdf Paper URL: https://www.ijtsrd.com/chemistry/other/43842/synthesis-of-15-benzodiazepines-a-review/deepali-mahajan
Microwave Assisted Synthesis, Structure, Spectral Characterization And Biolog...inventionjournals
International Journal of Pharmaceutical Science Invention (IJPSI) is an international journal intended for professionals and researchers in all fields of Pahrmaceutical Science. IJPSI publishes research articles and reviews within the whole field Pharmacy and Pharmaceutical Science, new teaching methods, assessment, validation and the impact of new technologies and it will continue to provide information on the latest trends and developments in this ever-expanding subject. The publications of papers are selected through double peer reviewed to ensure originality, relevance, and readability. The articles published in our journal can be accessed online.
Carbon Nitride Grafted Cobalt Complex (Co@npg-C3N4) for Visible LightAssiste...Pawan Kumar
1) A cobalt complex was covalently grafted to nanoporous graphitic carbon nitride (npg-C3N4) via a click reaction to create a heterogeneous photocatalyst called Co@npg-C3N4.
2) Under visible light irradiation at room temperature, Co@npg-C3N4 efficiently catalyzed the direct esterification of aldehydes without the need for an external base.
3) Characterization of Co@npg-C3N4 showed the cobalt complex was successfully immobilized via click chemistry, providing a robust photocatalyst that could be easily recovered and reused without significant loss of activity.
This document summarizes a dissertation on the synthesis and reactivity of heteryl-1,2,4-oxadiazoles. It describes two new methods for synthesizing 3-[1,2,4-oxadiazol-5-yl]coumarins, involving either a three-component condensation reaction or a Knoevenagel condensation of 5-cyanomethyl-1,2,4-oxadiazoles with salicylic aldehydes. It also details the synthesis of related compounds like 2-iminocoumarins and their derivatives obtained via substitution reactions of the 2-imino group. The reactivity of 4-[1,2,4-oxadiaz
When I was asked to give a companion lecture in support of ‘The Philosophy of Science’ (https://shorturl.at/4pUXz) I decided not to walk through the detail of the many methodologies in order of use. Instead, I chose to employ a long standing, and ongoing, scientific development as an exemplar. And so, I chose the ever evolving story of Thermodynamics as a scientific investigation at its best.
Conducted over a period of >200 years, Thermodynamics R&D, and application, benefitted from the highest levels of professionalism, collaboration, and technical thoroughness. New layers of application, methodology, and practice were made possible by the progressive advance of technology. In turn, this has seen measurement and modelling accuracy continually improved at a micro and macro level.
Perhaps most importantly, Thermodynamics rapidly became a primary tool in the advance of applied science/engineering/technology, spanning micro-tech, to aerospace and cosmology. I can think of no better a story to illustrate the breadth of scientific methodologies and applications at their best.
Microbiology of Central Nervous System INFECTIONS.pdfsammy700571
Microbiology of CNS infection
More Related Content
Similar to Asian Journal of Biochemical and Pharmaceutical Research Recent Advances on the Synthesis of Pyrazole-Containing Compounds of Potent Biological Activities and Study Their Chemical Applications
Synthesis, Characterization and Biological evaluation of substituted Pyrazole...SriramNagarajan15
The work presented in this article consists of synthesis, characterization and biological evaluation of substituted pyrazole derivatives. Pyrazole derivatives have been shown to have wide variety of pharmacological activities like antimicrobial, antiviral, antihistaminic, antitumor, antipyretic, anti-inflammatory, antidepressant and anticonvulsant. As combination of biologically active moieties into one molecule and synthesis of totally newer moieties have been the methods of research, we present here synthesis of some novel pyrazole derivatives incorporating various biologically active aryl/aryloxy acid derivatives such as ibuprofen, diclofenac, aceclofenac as well as potent antibacterial quinolones, norfloxacin and ciprofloxacin. All the compounds synthesized were evaluated for their antimicrobial activity.
This document summarizes a study on the synthesis of bromo and chloro derivatives of Baylis–Hillman adducts derived from nitroolefins. The researchers developed a simple protocol to synthesize these derivatives in good yields. They treated Baylis–Hillman adducts derived from nitroolefins with hydrobromic acid or iron chloride to obtain the bromo or chloro derivatives. The derivatives were characterized using NMR, IR and mass spectrometry. The novel bromo and chloro derivatives were shown to have potential as building blocks for a wide variety of organic compounds.
Sodium Hypophosphite An Efficient Catalyst for the Synthesis of 2 Substituted...ijtsrd
The preparation of one pot three components synthesis of 2 substituted Benzimidazole derivatives using reactants aldehyde o phenylenediamines and sodium hypophosphite as catalysis in solvent medium. Reaction is carried out at 800C for 1 to 2 hour gives high yield. Amit P. Tayade | Ramkrushna P. Pawar "Sodium Hypophosphite: An Efficient Catalyst for the Synthesis of 2-Substituted Benzimidazole" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-4 | Issue-3 , April 2020, URL: https://www.ijtsrd.com/papers/ijtsrd30622.pdf Paper Url :https://www.ijtsrd.com/chemistry/other/30622/sodium-hypophosphite-an-efficient-catalyst-for-the-synthesis-of-2substituted-benzimidazole/amit-p-tayade
IJERA (International journal of Engineering Research and Applications) is International online, ... peer reviewed journal. For more detail or submit your article, please visit www.ijera.com
Synthesis and Characterization of 3, 5-Diaryl-4-Benzoyl-1- Pyridoyl-Δ 2 - Pyr...IOSR Journals
This document summarizes the synthesis and characterization of 3,5-diaryl-4-benzoyl-1-pyridoyl-Δ2- pyrazolines. It describes the reaction of isoniazid with 3-aroyl flavanones in pyridine medium to synthesize these compounds. The structures of the synthesized compounds were established using spectral analysis and elemental analysis. Six compounds were successfully synthesized and their physical characterization data including melting points and molecular formulas are presented in Tables 1 and 2. The major advantage of this synthesis method is the ease of workup. These pyrazoline derivatives are reported to have various biological activities including antitubercular and antimicrobial properties.
This document summarizes the synthesis of new C-2, C-3 substituted heterocyclic derivatives of L-ascorbic acid and their characterization and evaluation of bacterial activity. Specifically, it describes the multi-step synthesis of Schiff bases and 1,3-oxazepine derivatives from L-ascorbic acid, including protection of hydroxyl groups, esterification, hydrazide formation, Schiff base formation with substituted benzaldehydes, and Diels-Alder reaction with phthalic anhydride to form 1,3-oxazepines. The synthesized compounds were characterized using melting point, FTIR, and 1H NMR spectroscopy and tested for antibacterial activity against gram-positive and
This document reviews recent developments in the diversity-oriented synthesis of heterocycles using multi-component reactions (MCRs). It provides examples of MCRs that construct 3 to 7-membered heterocyclic rings containing 1 to 4 heteroatoms of N, O, or S. The examples demonstrate how MCR conditions have improved over time, with reactions now occurring at room temperature rather than 360°C, in minutes rather than hours, and yielding products in nearly quantitative amounts. A variety of heterocycles can be synthesized through these efficient MCR approaches, including aziridines, azetidines, pyrroles, pyrrolidines, furans, indoles, pyrazoles, im
A series of novel 5-[2-(4-fluorobenzyl)-6-aryl-imidazo[2,1-b][1,3,4]thiadiazol-5-ylmethylene] thiazolidine-2,4-dione derivatives (4a-d) were synthesized. These final compounds (4a-d) were synthesized by Knoevenagel condensation of 2-(4-fluorobenzyl)-6-arylimidazo[2,1-b][1,3,4]thiadiazole-5-carbaldehydes (3a-d) with thiazolidine-2,4-dione. All the newly synthesized compounds were screened for their invivo hypoglycemic and hypolipidemic activity in male Wister rats. The Structures of all the newly synthesized compounds were established by analytical and spectral data.
Study of the Synthesis of Pyrrole and its Derivativesijtsrd
The article presents the theoretical studies results of hydraulic shock with flow continuity rupture in the pressure the pumping station pipeline. Calculated dependencies are obtained for calculating the shock pressure magnitude and the first period duration of reduced pressure, taking into account the hydraulic resistance along the pipeline length in the discontinuity event in the flow. The calculation results are compared with the Professor D.N. Smirnov"-™s experiments results.Comparative calculations using the proposed method with D.N. Smirnov experimental data gives a satisfactory agreement and confirms the proposed method reliability. Safarov Megli Djumayevich | Nazarov Asror Allanazarovich "Study of the Synthesis of Pyrrole and its Derivatives" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Special Issue | Modern Trends in Scientific Research and Development, Case of Asia , October 2020, URL: https://www.ijtsrd.com/papers/ijtsrd37971.pdf Paper Url :https://www.ijtsrd.com/economics/other/37971/study-of-the-synthesis-of-pyrrole-and-its-derivatives/safarov-megli-djumayevich
The document discusses various methods for synthesizing pyrazoles, including the Knorr pyrazole synthesis, reactions involving α,β-unsaturated aldehydes, β-hydroxy ketones, aromatic aldehydes, vinyl ketones, and more. It also covers pharmacological activities of pyrazoles such as antibacterial, antifungal, anticancer, anti-inflammatory, and anti-viral properties. Specific compounds are mentioned that have shown effectiveness against various bacterial, fungal, and viral strains. A wide range of synthetic routes and biological activities of pyrazoles and their derivatives are presented.
Synthesis and Characterization of Some Pyrazole Based Heterocyclic Compoundsijtsrd
This document summarizes a research article about the synthesis and characterization of pyrazole-based heterocyclic compounds. The article describes the synthesis of several pyrazole derivatives through multiple reaction steps starting from common organic compounds. The synthesized compounds were characterized using techniques like IR, NMR, and mass spectroscopy. Some of the compounds were found to have antimicrobial activity. In general, the document discusses the synthesis of novel pyrazole derivatives and characterization of their structures.
This document reviews 3,4-dihydropyrimidines thione, their chemistry and pharmacological potentials. It begins with background on pyrimidine structures and properties. It then discusses the chemical properties of pyrimidines and derivatives, including electrophilic and nucleophilic reactions. Biological importance is explained by pyrimidine's presence in nucleic acids, vitamins, and other biologically active compounds. Dihydropyrimidines are introduced as compounds obtained from cyclocondensation reactions. Several studies evaluating dihydropyrimidines as calcium channel blockers, antihypertensives, antibacterials, antifungals, and antioxidants are summarized.
This document describes the synthesis of novel spirooxindole derivatives via a three-component 1,3-dipolar cycloaddition reaction. Various spirooxindole-spiropiperidinone-pyrrolidine and spirooxindole-spiropiperidinone-pyrrolizine derivatives were synthesized in good yields from isatin, sarcosine or L-proline, and Knoevenagel adducts under optimized reaction conditions. The antimicrobial activities of the synthesized compounds were evaluated, with some compounds exhibiting excellent activity against bacteria and fungi, comparable or superior to standard antimicrobial drugs.
This document describes a one-pot synthesis of 3,4-dihydropyrimidin-2(1H)-ones and thiones using 4-nitrophthalic acid as a catalyst under solvent-free conditions. Various aldehydes, 1,3-dicarbonyl compounds, and urea or thiourea reacted smoothly in good to excellent yields. The reaction conditions were optimized to use a 2 mol% catalyst loading at 90°C for 30 minutes. 4-Nitrophthalic acid proved to be an effective and inexpensive catalyst for this Biginelli reaction, providing advantages over other reported catalysts such as higher yields, simpler workup, and an environmentally friendly procedure. The products were characterized
A Study of Synthesis and Characterization of Liquid Crystalline Substancesijtsrd
Synthesis of homologous series is achieved and having favourable geometry for the formation of mesophase along with formation of nano sized liquid crystal having good stability with metal free formulation which may be utilized further for the industrial application. The formation of liquid crystal with help of homologous series synthesized and characterization showed it to be metal free liquid crystal made up of oil, surfactant and co surfactant mixture which may open doors of nano gels, gels or microemulsion for liquid crystal. This along with texture study and magnetic study shows that unique properties were characterized and showed that metal free formation of liquid crystals with very less particle size and very good particle stability. M. H. Shah | D. K. Bhoi | M. B. Chauhan | N. B. Patel "A Study of Synthesis and Characterization of Liquid Crystalline Substances" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-6 | Issue-6 , October 2022, URL: https://www.ijtsrd.com/papers/ijtsrd51848.pdf Paper URL: https://www.ijtsrd.com/physics/other/51848/a-study-of-synthesis-and-characterization-of-liquid-crystalline-substances/m-h-shah
Synthesis of 1,5 Benzodiazepines A ReviewYogeshIJTSRD
Benzodiazepines are bicyclic heterocycles having medicinal importance. As a result several greener procedures have been developed using mild conditions and recyclable catalysts, easy work up good yields, multi component reactions less wastage and solvent less synthesis. Deepali Mahajan | Abhishek Raina "Synthesis of 1,5- Benzodiazepines: A Review" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-5 , August 2021, URL: https://www.ijtsrd.com/papers/ijtsrd43842.pdf Paper URL: https://www.ijtsrd.com/chemistry/other/43842/synthesis-of-15-benzodiazepines-a-review/deepali-mahajan
Microwave Assisted Synthesis, Structure, Spectral Characterization And Biolog...inventionjournals
International Journal of Pharmaceutical Science Invention (IJPSI) is an international journal intended for professionals and researchers in all fields of Pahrmaceutical Science. IJPSI publishes research articles and reviews within the whole field Pharmacy and Pharmaceutical Science, new teaching methods, assessment, validation and the impact of new technologies and it will continue to provide information on the latest trends and developments in this ever-expanding subject. The publications of papers are selected through double peer reviewed to ensure originality, relevance, and readability. The articles published in our journal can be accessed online.
Carbon Nitride Grafted Cobalt Complex (Co@npg-C3N4) for Visible LightAssiste...Pawan Kumar
1) A cobalt complex was covalently grafted to nanoporous graphitic carbon nitride (npg-C3N4) via a click reaction to create a heterogeneous photocatalyst called Co@npg-C3N4.
2) Under visible light irradiation at room temperature, Co@npg-C3N4 efficiently catalyzed the direct esterification of aldehydes without the need for an external base.
3) Characterization of Co@npg-C3N4 showed the cobalt complex was successfully immobilized via click chemistry, providing a robust photocatalyst that could be easily recovered and reused without significant loss of activity.
This document summarizes a dissertation on the synthesis and reactivity of heteryl-1,2,4-oxadiazoles. It describes two new methods for synthesizing 3-[1,2,4-oxadiazol-5-yl]coumarins, involving either a three-component condensation reaction or a Knoevenagel condensation of 5-cyanomethyl-1,2,4-oxadiazoles with salicylic aldehydes. It also details the synthesis of related compounds like 2-iminocoumarins and their derivatives obtained via substitution reactions of the 2-imino group. The reactivity of 4-[1,2,4-oxadiaz
Similar to Asian Journal of Biochemical and Pharmaceutical Research Recent Advances on the Synthesis of Pyrazole-Containing Compounds of Potent Biological Activities and Study Their Chemical Applications (20)
When I was asked to give a companion lecture in support of ‘The Philosophy of Science’ (https://shorturl.at/4pUXz) I decided not to walk through the detail of the many methodologies in order of use. Instead, I chose to employ a long standing, and ongoing, scientific development as an exemplar. And so, I chose the ever evolving story of Thermodynamics as a scientific investigation at its best.
Conducted over a period of >200 years, Thermodynamics R&D, and application, benefitted from the highest levels of professionalism, collaboration, and technical thoroughness. New layers of application, methodology, and practice were made possible by the progressive advance of technology. In turn, this has seen measurement and modelling accuracy continually improved at a micro and macro level.
Perhaps most importantly, Thermodynamics rapidly became a primary tool in the advance of applied science/engineering/technology, spanning micro-tech, to aerospace and cosmology. I can think of no better a story to illustrate the breadth of scientific methodologies and applications at their best.
The binding of cosmological structures by massless topological defectsSérgio Sacani
Assuming spherical symmetry and weak field, it is shown that if one solves the Poisson equation or the Einstein field
equations sourced by a topological defect, i.e. a singularity of a very specific form, the result is a localized gravitational
field capable of driving flat rotation (i.e. Keplerian circular orbits at a constant speed for all radii) of test masses on a thin
spherical shell without any underlying mass. Moreover, a large-scale structure which exploits this solution by assembling
concentrically a number of such topological defects can establish a flat stellar or galactic rotation curve, and can also deflect
light in the same manner as an equipotential (isothermal) sphere. Thus, the need for dark matter or modified gravity theory is
mitigated, at least in part.
Describing and Interpreting an Immersive Learning Case with the Immersion Cub...Leonel Morgado
Current descriptions of immersive learning cases are often difficult or impossible to compare. This is due to a myriad of different options on what details to include, which aspects are relevant, and on the descriptive approaches employed. Also, these aspects often combine very specific details with more general guidelines or indicate intents and rationales without clarifying their implementation. In this paper we provide a method to describe immersive learning cases that is structured to enable comparisons, yet flexible enough to allow researchers and practitioners to decide which aspects to include. This method leverages a taxonomy that classifies educational aspects at three levels (uses, practices, and strategies) and then utilizes two frameworks, the Immersive Learning Brain and the Immersion Cube, to enable a structured description and interpretation of immersive learning cases. The method is then demonstrated on a published immersive learning case on training for wind turbine maintenance using virtual reality. Applying the method results in a structured artifact, the Immersive Learning Case Sheet, that tags the case with its proximal uses, practices, and strategies, and refines the free text case description to ensure that matching details are included. This contribution is thus a case description method in support of future comparative research of immersive learning cases. We then discuss how the resulting description and interpretation can be leveraged to change immersion learning cases, by enriching them (considering low-effort changes or additions) or innovating (exploring more challenging avenues of transformation). The method holds significant promise to support better-grounded research in immersive learning.
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdfSelcen Ozturkcan
Ozturkcan, S., Berndt, A., & Angelakis, A. (2024). Mending clothing to support sustainable fashion. Presented at the 31st Annual Conference by the Consortium for International Marketing Research (CIMaR), 10-13 Jun 2024, University of Gävle, Sweden.
Microbial interaction
Microorganisms interacts with each other and can be physically associated with another organisms in a variety of ways.
One organism can be located on the surface of another organism as an ectobiont or located within another organism as endobiont.
Microbial interaction may be positive such as mutualism, proto-cooperation, commensalism or may be negative such as parasitism, predation or competition
Types of microbial interaction
Positive interaction: mutualism, proto-cooperation, commensalism
Negative interaction: Ammensalism (antagonism), parasitism, predation, competition
I. Mutualism:
It is defined as the relationship in which each organism in interaction gets benefits from association. It is an obligatory relationship in which mutualist and host are metabolically dependent on each other.
Mutualistic relationship is very specific where one member of association cannot be replaced by another species.
Mutualism require close physical contact between interacting organisms.
Relationship of mutualism allows organisms to exist in habitat that could not occupied by either species alone.
Mutualistic relationship between organisms allows them to act as a single organism.
Examples of mutualism:
i. Lichens:
Lichens are excellent example of mutualism.
They are the association of specific fungi and certain genus of algae. In lichen, fungal partner is called mycobiont and algal partner is called
II. Syntrophism:
It is an association in which the growth of one organism either depends on or improved by the substrate provided by another organism.
In syntrophism both organism in association gets benefits.
Compound A
Utilized by population 1
Compound B
Utilized by population 2
Compound C
utilized by both Population 1+2
Products
In this theoretical example of syntrophism, population 1 is able to utilize and metabolize compound A, forming compound B but cannot metabolize beyond compound B without co-operation of population 2. Population 2is unable to utilize compound A but it can metabolize compound B forming compound C. Then both population 1 and 2 are able to carry out metabolic reaction which leads to formation of end product that neither population could produce alone.
Examples of syntrophism:
i. Methanogenic ecosystem in sludge digester
Methane produced by methanogenic bacteria depends upon interspecies hydrogen transfer by other fermentative bacteria.
Anaerobic fermentative bacteria generate CO2 and H2 utilizing carbohydrates which is then utilized by methanogenic bacteria (Methanobacter) to produce methane.
ii. Lactobacillus arobinosus and Enterococcus faecalis:
In the minimal media, Lactobacillus arobinosus and Enterococcus faecalis are able to grow together but not alone.
The synergistic relationship between E. faecalis and L. arobinosus occurs in which E. faecalis require folic acid
JAMES WEBB STUDY THE MASSIVE BLACK HOLE SEEDSSérgio Sacani
The pathway(s) to seeding the massive black holes (MBHs) that exist at the heart of galaxies in the present and distant Universe remains an unsolved problem. Here we categorise, describe and quantitatively discuss the formation pathways of both light and heavy seeds. We emphasise that the most recent computational models suggest that rather than a bimodal-like mass spectrum between light and heavy seeds with light at one end and heavy at the other that instead a continuum exists. Light seeds being more ubiquitous and the heavier seeds becoming less and less abundant due the rarer environmental conditions required for their formation. We therefore examine the different mechanisms that give rise to different seed mass spectrums. We show how and why the mechanisms that produce the heaviest seeds are also among the rarest events in the Universe and are hence extremely unlikely to be the seeds for the vast majority of the MBH population. We quantify, within the limits of the current large uncertainties in the seeding processes, the expected number densities of the seed mass spectrum. We argue that light seeds must be at least 103 to 105 times more numerous than heavy seeds to explain the MBH population as a whole. Based on our current understanding of the seed population this makes heavy seeds (Mseed > 103 M⊙) a significantly more likely pathway given that heavy seeds have an abundance pattern than is close to and likely in excess of 10−4 compared to light seeds. Finally, we examine the current state-of-the-art in numerical calculations and recent observations and plot a path forward for near-future advances in both domains.
Travis Hills of MN is Making Clean Water Accessible to All Through High Flux ...Travis Hills MN
By harnessing the power of High Flux Vacuum Membrane Distillation, Travis Hills from MN envisions a future where clean and safe drinking water is accessible to all, regardless of geographical location or economic status.
Candidate young stellar objects in the S-cluster: Kinematic analysis of a sub...Sérgio Sacani
Context. The observation of several L-band emission sources in the S cluster has led to a rich discussion of their nature. However, a definitive answer to the classification of the dusty objects requires an explanation for the detection of compact Doppler-shifted Brγ emission. The ionized hydrogen in combination with the observation of mid-infrared L-band continuum emission suggests that most of these sources are embedded in a dusty envelope. These embedded sources are part of the S-cluster, and their relationship to the S-stars is still under debate. To date, the question of the origin of these two populations has been vague, although all explanations favor migration processes for the individual cluster members. Aims. This work revisits the S-cluster and its dusty members orbiting the supermassive black hole SgrA* on bound Keplerian orbits from a kinematic perspective. The aim is to explore the Keplerian parameters for patterns that might imply a nonrandom distribution of the sample. Additionally, various analytical aspects are considered to address the nature of the dusty sources. Methods. Based on the photometric analysis, we estimated the individual H−K and K−L colors for the source sample and compared the results to known cluster members. The classification revealed a noticeable contrast between the S-stars and the dusty sources. To fit the flux-density distribution, we utilized the radiative transfer code HYPERION and implemented a young stellar object Class I model. We obtained the position angle from the Keplerian fit results; additionally, we analyzed the distribution of the inclinations and the longitudes of the ascending node. Results. The colors of the dusty sources suggest a stellar nature consistent with the spectral energy distribution in the near and midinfrared domains. Furthermore, the evaporation timescales of dusty and gaseous clumps in the vicinity of SgrA* are much shorter ( 2yr) than the epochs covered by the observations (≈15yr). In addition to the strong evidence for the stellar classification of the D-sources, we also find a clear disk-like pattern following the arrangements of S-stars proposed in the literature. Furthermore, we find a global intrinsic inclination for all dusty sources of 60 ± 20◦, implying a common formation process. Conclusions. The pattern of the dusty sources manifested in the distribution of the position angles, inclinations, and longitudes of the ascending node strongly suggests two different scenarios: the main-sequence stars and the dusty stellar S-cluster sources share a common formation history or migrated with a similar formation channel in the vicinity of SgrA*. Alternatively, the gravitational influence of SgrA* in combination with a massive perturber, such as a putative intermediate mass black hole in the IRS 13 cluster, forces the dusty objects and S-stars to follow a particular orbital arrangement. Key words. stars: black holes– stars: formation– Galaxy: center– galaxies: star formation
Discovery of An Apparent Red, High-Velocity Type Ia Supernova at 𝐳 = 2.9 wi...Sérgio Sacani
We present the JWST discovery of SN 2023adsy, a transient object located in a host galaxy JADES-GS
+
53.13485
−
27.82088
with a host spectroscopic redshift of
2.903
±
0.007
. The transient was identified in deep James Webb Space Telescope (JWST)/NIRCam imaging from the JWST Advanced Deep Extragalactic Survey (JADES) program. Photometric and spectroscopic followup with NIRCam and NIRSpec, respectively, confirm the redshift and yield UV-NIR light-curve, NIR color, and spectroscopic information all consistent with a Type Ia classification. Despite its classification as a likely SN Ia, SN 2023adsy is both fairly red (
�
(
�
−
�
)
∼
0.9
) despite a host galaxy with low-extinction and has a high Ca II velocity (
19
,
000
±
2
,
000
km/s) compared to the general population of SNe Ia. While these characteristics are consistent with some Ca-rich SNe Ia, particularly SN 2016hnk, SN 2023adsy is intrinsically brighter than the low-
�
Ca-rich population. Although such an object is too red for any low-
�
cosmological sample, we apply a fiducial standardization approach to SN 2023adsy and find that the SN 2023adsy luminosity distance measurement is in excellent agreement (
≲
1
�
) with
Λ
CDM. Therefore unlike low-
�
Ca-rich SNe Ia, SN 2023adsy is standardizable and gives no indication that SN Ia standardized luminosities change significantly with redshift. A larger sample of distant SNe Ia is required to determine if SN Ia population characteristics at high-
�
truly diverge from their low-
�
counterparts, and to confirm that standardized luminosities nevertheless remain constant with redshift.
Asian Journal of Biochemical and Pharmaceutical Research Recent Advances on the Synthesis of Pyrazole-Containing Compounds of Potent Biological Activities and Study Their Chemical Applications
1. See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/279511794
Asian Journal of Biochemical and Pharmaceutical Research Recent Advances
on the Synthesis of Pyrazole-Containing Compounds of Potent Biological
Activities and Study Their Chemical...
Article · November 2014
CITATIONS
3
READS
627
1 author:
Taha Eldebss
Cairo University
41 PUBLICATIONS 746 CITATIONS
SEE PROFILE
All content following this page was uploaded by Taha Eldebss on 01 July 2015.
The user has requested enhancement of the downloaded file.
2. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014 ISSN: 2231-2560
CODEN (USA): AJBPAD
Review Article
356
Asian Journal of Biochemical and Pharmaceutical Research
Recent Advances on the Synthesis of Pyrazole-Containing Compounds of Potent
Biological Activities and Study Their Chemical Applications
Taha M.A Eldebss
Department of Chemistry, Faculty of Science, University of Cairo, Giza 12613, Egypt
Received: 16 September 2014; Revised: 14 October 2014; Accepted: 19 November 2014
Abstract: Several pyrazoles with different substitutions at different position were synthesized starting from
pyrazole and its derivatives. The biological activities of newly synthesized compounds were tested and
evaluated in vivo and vitro for different types of diseases and exhibited good results, in addition to some
examples of some Pyrazoles Containing Compounds were established as drugs such as Celecoxib Lesopitron
Sulfaphenazole Rimonabant Tebufenpyrad Betazole Tepoxalin Pyriprole Deracoxib Mavacoxib.
Keywords: Pyrazole, Celecoxib, Lesopitron, Pyriprole, Yellow 2G, Fipronil RS.
INTRODUCTION:
Structurally unique and functionality-enriched heterocyclic systems are of great significance in
chemically and biologically related research areas.[ 2-112, 187-134] In particular, pyrazole and their
derivatives are an important classes of compounds and has been widely found in biologically active
molecules and drug candidates. Moreover, diversely functionalized pyrazole have also been identified
as versatile synthetic building blocks for the construction of complex molecules and natural products.
Therefore, great efforts have been done to their preparations and chemical application.
3 -Properties of pyrazole as in Fig.1
Fig.1
Pyrazole (Systematic or IUPAC name 1,2-Diazole) It is a heterocyclic organic compound
characterized by a 5-membered ring of three carbon atoms and two adjacent nitrogen centres with the
molecular formula C3H4N2 ; molar mass, 68.08 g mol−1; melting point, 66–70 °C, boiling point,
3. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
357
186–188 °C ; basicity (pKb), 2.5, . Pyrazoles are also the class of compounds that have the ring
C3N2 with adjacent nitrogen centres [1].
4- Chemical reactivity and application of pyrazoles
4-1) Methods of Synthesis of pyrazoles
4-1-1) Synthesis of unsubstitute Pyrazole
Pyrazole was synthesized by the reaction of α,β-unsaturated aldehydes with hydrazine and subsequent
dehydrogenation as in Scheme1 [113].
Scheme 1
4-1-2))Knorr pyrazole synthesis The Knorr pyrazole synthesis is an organic reaction used to convert a
hydrazine or its derivatives and a 1,3-dicarbonyl compound to a pyrazole using an acid catalyst via the
following mechanism as in Scheme 2 [114].
R1
O
R3
O
R2
H3O
R1
OH
R3
O
R2
RNHNH2
-H2O
R1
OH
R3
O
R2
RNHNH2
H2O
-H3O R1
OH
R3
O
R2
RNHNH
R1 R3
O
R2
RNHN
H3O
-H2O
R1 R3
OH
R2
RNHN
-H2O N
N
R3
OH
R1
R2
R
H
N
N
R3
R1
R2
Scheme :2
4-1-3) Substituted and unsubstituted pyrazoles are prepared by condensation of 1,3-diketones with
hydrazine. For example, acetylacetone and hydrazine gives 3,5-dimethylpyrazole as in Scheme 3
[115].
CH3C(O)CH2C(O)CH3 + N2H4 → (CH3)2C3HN2H + 2 H2O
Scheme 3
Also, pyrazole was synthesized from acetylene and diazomethane[116].
4. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
358
4-2) Synthesis of substituted pyrazole
4-2-1)Synthesis of novel pyrazole-based heterocycles via a copper(II)-catalysed domino annulations
Pyrazole-based β-aminonitriles and β-amino-carbaldehydes as bifunctional building blocks are
introduced in a facile copper(II)-catalysed one-pot domino generation of multiple N-containing
heterobi- and tricycles. This streamlined synthetic approach permits easy access to novel pyrazole-
fused imidazo- and pyrimido[1,2-c]pyrimidinones and to pyrazolo[3,4-d]pyrimidinone species with
isolated yields up to 90%. The present study also reveals a unique amine–isocyanate coupling
promotion via copper(II)-based catalytic activation as in Scheme 4 [117].
Scheme 4
4-2-2) Heterocycle formation from 1,3-dinitroalkanes. A novel pyrazole synthesis: Combinatorial
Chemistry Review.Aliphatic nitro compounds have proved to be useful starting materials in organic
synthesis. When the nitro compounds are properly substituted they can cyclize, yielding heterocyclic
compounds. 1,3-Dinitroalkanes can be viewed as synthetic equivalents for 1,3-dicarbonyl compounds
through a Nef, or equivalent, reaction, and therefore could be ultimately converted into azole
heterocycles. Application of the Nef reaction under the usual conditions (NaOH; conc. H2SO4) to 1,3-
dinitroalknes gives only trace amounts of the anticipated dione, although the yields can be increased
(up to 40%) using a secondary amine as the base. We now find that 1,3-dinitroalkanes react with
hydrazines giving rise to pyrazoles as in Scheme 5 [118].
Scheme 5
5. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
359
4-2-3) An efficient, general, one-pot, three-component procedure for the preparation of 3,5-
disubstituted 1H-pyrazoles includes condensation of substituted aromatic aldehydes and
tosylhydrazine followed by cycloaddition with terminal alkynes. The reaction tolerates various
functional groups and sterically hindered substrates to afford the desired pyrazoles in good yields as in
Scheme 6 [119].
Scheme 6
4-2-4) 1,3-Diketones, which were synthesized in situ from ketones and acid chlorides, were converted
into pyrazoles by the addition of hydrazine. This method allows a fast and general synthesis of
previously inaccessible pyrazoles and synthetically demanding pyrazole-containing fused rings as in
Scheme 7 [120].
Scheme 7
4-2-5) A highly regioselective synthesis of 1-aryl-3,4,5-substituted pyrazoles based on the
condensation of 1,3-diketones with arylhydrazines proceeds at room temperature in N,N-
dimethylacetamide and furnishes pyrazoles in good yields as in Scheme 8[121].
.
Scheme 8
4-2-6) Pyrazole or isoxazole derivatives are prepared by a palladium-catalyzed four-component
coupling of a terminal alkyne, hydrazine (hydroxylamine), carbon monoxide under ambient pressure,
and an aryl iodide as in Scheme 9[122].
6. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
360
Scheme 9
4-2-7) Also, pyrazoles derivatives were obtained via reaction of aryl halides with 1,3-diones as in
Scheme 10[123].
Scheme 10
4-2-8) pyrazoles derivatives were obtained via one-pot, three-components synthesis as in Scheme
11[124].
Scheme 11
4-2-9) A regioselective synthesis of tri- or tetrasubstituted pyrazoles by the reaction of hydrazones
with nitroolefins mediated with strong bases such as t-BuOK exhibits a reversed, exclusive 1,3,4-
regioselectivity. Subsequent quenching with strong acids such as TFA is essential to achieve good
yields. A stepwise cycloaddition reaction mechanism is proposed as in Scheme 12[125].
Scheme 12
4-2-10) Two general protocols for the reaction of electron-deficient N-arylhydrazones with
nitroolefins allow a regioselective synthesis of 1,3,5-tri- and 1,3,4,5-tetrasubstituted pyrazoles. Studies
on the stereochemistry of the key pyrazolidine intermediate suggest a stepwise cycloaddition
mechanism as in Scheme 13[126].
7. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
361
Scheme 13
4-2-11) A regioselective one-pot synthesis of substituted pyrazoles from N-monosubstituted
hydrazones and nitroolefins gives products in good yields. A key nitropyrazolidine intermediate is
characterized and a plausible mechanism is proposed as in Scheme 14[127].
Scheme 14
4-2-12) An unprecedented ruthenium(II)-catalyzed oxidative C-N coupling method enables a facile
intramolecular synthesis of various synthetically challenging tri- and tetrasubstituted pyrazoles in the
presence of oxygen as oxidant. The reaction demonstrates excellent reactivity, functional group
tolerance, and high yields as in Scheme 15[128].
Scheme 15
4-2-13) A general, highly flexible Cu-catalyzed domino C-N coupling/hydroamination reaction
constitutes a straightforward alternative to existing methodology for the preparation of pyrroles and
pyrazoles as in Scheme 16[129].
Scheme 16
4-2-14) Alumino-heteroles are obtained from simple precursors in a fully chemo- and regioselective
manner by a metalative cyclization. The carbon-aluminum bond is still able to react further with
several electrophiles, without the need of transmetalation providing a straightforward access to 3,4,5-
trisubstituted isoxazoles and 1,3,4,5-tetrasubstituted pyrazoles as in Scheme 17[130].
8. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
362
Scheme 17
4-2-15) Various 1-acyl-5-hydroxy-4,5-dihydro-1H-pyrazoles have been prepared in good yields from
the corresponding 2-alkyn-1-ones. The resulting dihydropyrazoles undergo dehydration and iodination
in the presence of ICl and Li2CO3 at room temperature to provide 1-acyl-4-iodo-1H-pyrazoles as in
Scheme 18[131].
Scheme 18
4-2-16) A tandem catalytic cross-coupling/electrocyclization allows the conversion of differentially
substituted acyclic and cyclic enol triflates and an elaborated set of diazoacetates to provide the
corresponding 3,4,5-trisubstituted pyrazoles with a high degree of structural complexity as in Scheme
19[132].
Scheme 19
4-2-17) A series of 4-substituted 1H-pyrazole-5-carboxylates was prepared from the
cyclocondensation reaction of unsymmetrical enaminodiketones with tert-butylhydrazine
hydrochloride or carboxymethylhydrazine. The compounds were obtained regiospecifically and in
very good yields as in Scheme 20[133].
Scheme 20
9. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
363
4-2-18) An easy and efficient copper-catalyzed reaction for the synthesis of polysubstituted pyrazoles
from phenylhydrazones and dialkyl ethylenedicarboxylates tolerates a range of functionalities, and the
corresponding adducts can be obtained in moderate to good yields as in Scheme 21[134].
Scheme 21
4-2-19) The reaction of diazo(trimethylsilyl)methylmagnesium bromide with aldehydes or ketones
gave 2-diazo-2-(trimethylsilyl)ethanols, which were applied to the synthesis of di- and trisubstituted
pyrazoles via [3+2] cycloaddition reaction with ethyl propiolate or dimethyl acetylenedicarboxylate as
in Scheme 22[135].
Scheme 22
4-2-20) In the presence of activated carbon, Hantzsch 1,4-dihydropyridines and 1,3,5-trisubstituted
pyrazolines were aromatized with molecular oxygen to the corresponding pyridines and pyrazoles in
excellent yields as in Scheme 23[136].
.
Scheme 23
4-2-21) CuI-catalyzed coupling of N-acyl-N′-substituted hydrazines with aryl iodides affords N-acyl-
N′,N′-disubstituted hydrazines regioselectively. N-Acyl-N′-substituted hydrazines can also react with
2-bromoarylcarbonylic compounds in the presence of 4-hydroxy-L-proline as ligand to provide 1-aryl-
1H-indazoles as in Scheme 24[137].
10. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
364
Scheme 24
4-2-22) Various N-aryl-1H-indazoles and benzimidazoles were synthesized from common arylamino
oximes in good to excellent yields depending upon the base used in the reaction. Triethylamine
promoted the formation of benzimidazoles, whereas 2-aminopyridine promoted the formation of N-
arylindazoles as in Scheme 25[138].
Scheme 25
4-2-23) A rapid and efficient synthesis of 2H-indazoles, which involves a [3 + 2] dipolar
cycloaddition of arynes and sydnones, proceeds under mild reaction conditions in good to excellent
yields as in Scheme 26[139].
.
Scheme 26
4-2-24) The 1H-indazole skeleton can be constructed by a [3 + 2] annulation approach from arynes
and hydrazones. Under different reaction conditions, both N-tosylhydrazones and N-
aryl/alkylhydrazones can be used to afford various indazoles as in Scheme 27[140].
11. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
365
.
Scheme 27
4-2-25) Readily available, stable, and inexpensive N-tosylhydrazones react with arynes under mild
reaction conditions to afford 3-substituted indazoles in good yields. The reaction involves a 1,3-dipolar
cycloaddition of in situ generated diazo compounds and arynes as in Scheme 28[141].
.
Scheme 28
4-2-26) The [3+2] cycloaddition of a variety of diazo compounds with o-(trimethylsilyl)aryl triflates in
the presence of CsF or TBAF at room temperature provides a very direct, efficient approach to a wide
range of potentially biologically and pharmaceutically interesting substituted indazoles in good to
excellent yields under mild reaction conditions as in Scheme 29[142].
.
Scheme 29
4-2-27) 2H-Indazoles are synthesized using a copper-catalyzed one-pot, three-component reaction of
2-bromobenzaldehydes, primary amines, and sodium azide. The catalyst plays the key role in the
formation of C-N and N-N bonds. This method has a broad substrate scope with a high tolerance for
various functional groups as in Scheme 30[143].
Scheme 30
4-2-28) A general two-step synthesis of substituted 3-aminoindazoles from 2-bromobenzonitriles
involves a palladium-catalyzed arylation of benzophenone hydrazone followed by an acidic
deprotection/cyclization sequence. This procedure offers a general and efficient alternative to the
typical SNAr reaction of hydrazine with o-fluorobenzonitriles as in Scheme 31[144].
12. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
366
Scheme 31
4-2-29) Compounds containing imine showed high insecticidal activity against cotton bollworm. The
compounds also had good activities against bean aphid and mosquito as in Scheme 32[145].
Scheme 32
4-2-30) One-pot three-components synthesis of benzochromeno-pyrazole derivatives as in Scheme
33[146].
Scheme 33
4-2-31) pyrazole carboxylate derivatives can be converted into pyrazolotriazolo, pyrazolo thiadiazolo,
pyrazolo oxiadiazolo and bipyrazolo derivatives as in Schemes 34, 35, 36, 37 and 38 [5].
Ph
N N
Ph
CN OC2H5
O
Ph
N
N
Ph
CN
H
N
N N
HS
NH2NH2 / R.T
S
NHNH2
H2N
KSCN
KOH
OR
Scheme 34
13. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
367
Ph
N N
Ph
CN OC2H5
O
Ph
N
N
Ph
CN
N
N N
Y
NH2NH2 / R.T
S
NHNH2
H2N
/ KSCN
KOH
Or
Or PhCNS/KOH/NH2NH2
Or CS2/KOH/NH2NH2
X
X = H, NH2, Ph
Y = SH, SH, NH2NH2
Scheme 35
ٍ◌Scheme 36
PhNCS
Ph
N
N
Ph
CN
S
N N
PhHN
H2SO4
Ph
N
N
Ph
CN
HN
O
NH2
Ph
N
N
Ph
CN
O
N N
HS
CS2 / KOH
Reflux
Scheme 37
O
O
O
OEt
O
Ph
N
N
Ph
NC
O
N
N
Ph
N N
Ph
NC O
N
N
O
Ph
N
N
Ph
CN
HN
O
NH2
Scheme 38
Ph
N N
Ph
CN OC2H5
O
Ph
N
N
Ph
CN
H
N
N N
HS
NH2NH2 / R.T
S
NHNH2
H2N
KSCN
KOH
OR
14. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
368
4-2-32) pyrazole enaminone derivatives can be converted into pyrazolo pyrazolopyradizine and
bipyrazolo derivatives as in Schemes 39, 40, 41[4].
Ph
N
N
NC
O
N
Dry benzene/
Et3N/
N
N
Ph
N
N
N
N
Ar
Ph
NC
X
NH2NH2
Ph
YCOC(Cl)NNHAr
Y
X
CH3, OMe
CH3, OH
Scheme 39
Ph
N
N
NC
O
N
Dry benzene/
Et3N/
N
N
Ph
Ph
NC
NH2NH2
Ph
PhNHCOC(Cl)NNHAr
O
N
N
NH
O
Ar
Ph
N
N
Ph
Ph
NC
O
N
N
Ph
Ph
PhC(Cl)NNHAr
Dry benzene/
Et3N/ NH2NH2
Scheme 40
Ph
N
N
Ph
NC
O Br
N NH
Ar
N
N
Ph
N
N
N
N
Ar
Ph
NC
NH
N
N CN
Ph Ph
Ph
N
N
NC
O
N
Dry benzene/
Et3N/ NH2NH2
Ph
Scheme 41
4-2-33) Enaminone reacts with hydrazines , hydroxylamine and guanidine to afford the novel
pyrazole, isoxazole and pyrimidine derivatives, respectively. It reacts also with aminopyrazole
derivatives to pyrazolo[1,5-a]pyrimidine derivatives. Reaction of the enaminone reacts with
benzoquinone and naphthoquinone led to the formation benzofuran derivatives, respectively. In
15. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
369
addition, it reacts with hippuric acid to afford the corresponding pyrazolyl pyranone derivative as in
Scheme 42[147].
N
X
H2N NH2
NH
NH2X
, X= O,N ,NPh
N
N
H3C
Ph
O
NMe2
N
N
H3C
Ph
N
N
H3C
Ph
N
N
NH2
N
NH
NH2
N
N
N
R2
R1
R1
R2
N
N
H3C
Ph
O
O
O
O
N
N
H3C
Ph
O
OH
O
N
N
H3C
Ph
O
OH
O
COOH
HN
O
Ph O O
H
N O
Ph
N
N
H3C
Ph
Scheme 42
4-2-34) Enaminone undergoes regioselective 1,3-dipolar cycloaddition with nitrilimines and nitrile
oxides to afford the novel pyrazole and isoxazole derivatives, respectively. It reacts also with 1H-
benzimidazole-2-acetonitrile, 2-aminobenzimidazole and 3-amino-1,2,4-triazole to afford the novel
pyrido[1,2-a]benzimidazole, pyrimido[1,2-a]benzimidazole and the triazolo[1,5-a]pyrimidine
derivatives, respectively as in Scheme 43[148].
16. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
370
N
N
CH3
Ph
N
N
CN
N N
CH3
Ph
N
N
N
N
N N
CH3
Ph
N
N
N
N
N
N N
CH3
Ph
N
N
CH3
Ar
N
N
CH3
Ph
O
H3C
R
O
N
Z
ArHN
Z = Cl, Br
R = CH
3, OEt
-HNMe2
N
H
N CN
N
H
N
NH2
N
N
NH
NH2
Scheme 43
4-2-35) simple, facile, efficient and three-components procedure for the synthesis Pyrazolo[3,4-
b]pyridines utilizing phenylsulphone synthon, under ultrasonic irradiation as in Scheme 44[149].
abs. ethanol /
p-TsOH
))) or Reflux
+
N
N
Ph
NH2
N
N N
Ph
Ar
Ph
R R
Ph
O
S
O O
Ph
Ar
Scheme 44
4-2-36)-J. K. Sneed et.al reported[ 150, 151] that 3, 5-Di (2-pyridyl) pyrazole 26 was first obtained in
the reaction of 1, 3-di (2-pyridyl) propane-1, 3-dione 25 with hydrazine hydrate. A series of mono- and
di (4-pyridyl)-substituted pyrazoles were synthesized using the same approach as in Scheme 45.
N
N
H
N
R
N
O
R
O
NH2NH2
Scheme 45
4-2-37)-J A. Silkhankova et.al reported [152, 153] a large volume of the research was done by the
authors who synthesized a series of symmetrical and unsymmetrical 3, 5-dipyridyl-substituted
pyrazoles as in Scheme 46.
17. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
371
N
N
R3
R2
R1
O
R2
O
R3NHNH2 R1
Scheme 46
4-2-37)-A biologically active series of substituted pyrazoles were synthesized as in Fig.2 [154].
Fig.2
4-2-38)-4-iodopyrazoles was synthesized under microwave conditions as in Scheme 47[155].
N
N
H
N
N
H
microwave or
coventional heated
75-77%
I
Scheme 47
4-2-39)-N-Substituted benzoylpyrazoles as shown below as in Scheme 48[156].
R1
F3C
OH
O
EtOH / H+
N2H4 (aq.)
R1
F3C
NH-NH2
O
R1
F3C
N
O
N
H3C
CH3
O O
Scheme 48
4-1-3) Pyrazoles as key synthon in Synthesis of alkaloids
18. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
372
Synthetic Photochemistry of sceptrin alkaloids: In a recent publication Professor Birman and one of
his colleagues reported a novel way to synthesize a molecule called dibromosceptrin
(C22H23Br4N10O2), shown here as in Scheme 49[157].
Scheme 49
5-Biological activities of pyrazoles
Pyrazoles are present in medicinally important compounds either for human being or for veterinary
medicine or other applications
5-1) Applications In human being medicine as in Fig.3
(a)Celecoxib ( 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide), it is a
highly selective COX-2 inhibitor[158-160].
(b) Lesopitron ( 2-{4-[4-(4-chloro-1H-pyrazol-1-yl)butyl]piperazin-1-yl}pyrimidine ), it is a selective
full agonist of the 5-HT1A receptor[161].
(c) Sulfaphenazole (4-amino-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide Sulfaphenazole), it is
a sulfonamide antibacterial[162].
(d) O-12695 (4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-pentylpyrazole-3-carboxamide), it
acts as cannabinoid antagonist drugs [163-165].
19. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
373
(e) Rimonabant 5-(4-Chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-
pyrazole-3-carboxamide is an anorectic antiobesity drug[166] .
(f) VCHSR(5-(4-chlorophenyl)- 3-[(E)-2-cyclohexylethenyl]- 1-(2,4-dichlorophenyl)- 4-methyl- 1H-
pyrazole), it is a drug acts as a selective antagonist of the cannabinoid receptor CB1[167,168].
(g) Tebufenpyrad (N-(4-tert-Butylbenzyl)-4-chloro-3-ethyl-1-methylpyrazole-5-carboxamide or4-
Chloro-N-[[4-(1,1-dimethylethyl)phenyl]]methyl]-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide )is a
commonly used in commercial greenhouses[169].
(h) AM2511 (2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-(1-piperidyl)pyrazole-3-
carboxamide), it is an inverse agonist at the CB1 cannabinoid receptor[170].
(i) Betazole (2-(2H-Pyrazol-3-yl)ethanamine), it is a histamine H2 receptor agonist. as a gastric
stimulant [171,172].
(j) E-55888 (N,N-dimethyl-3-(1,3,5-trimethyl-1H-pyrazol-4-yl)phenethylamine) it is anti-
hyperalgesic but not analgesic[173,174].
(b) (c)
(d) (e) (f)
(g) (h) (i)
20. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
374
(j) Fig. 3
5-2) Applications In veterinary medicine as in Fig.4
Tepoxalin(3-[5-(4-Chlorophenyl)-1-(4-methoxyphenyl)pyrazol-3-yl]-N-hydroxy-N-
methylpropanamide), it is a nonsteroidal anti-inflammatory drug approved for veterinary use (in
dogs)[175].
(b)Pyriprole(1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(difluoromethyl)thio]-5-[(2-
pyridinylmethyl)amino]-1H-pyrazole-3-carbonitrile) it is for veterinary use on dogs against external
parasites, fleas and ticks[176].
(c)Deracoxib4-[3-(Difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazole-1-yl]
benzenesulfonamide Deracoxib used in veterinary medicine to treat osteoarthritis in dogs[177].
(d) Mavacoxib (4-[5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide) it is a
veterinary drug used to treat pain and inflammation in dogs with degenerative joint disease[178]. It
acts as a COX-2 inhibitor[179].
(a) (b) (c)
(d) Fig.4
5-3) Applications In food chemistry as in Fig.5
(a) Yellow 2G ( Disodium 2,5-dichloro-4-[3-methyl-5-oxo-4-(4-sulfonatophenyl)diazenyl-4H-pyrazol-
1-yl]benzenesulfonate) it is a food coloring[180].
(b) Tartrazine (Trisodium (4E)-5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)hydrazono]-3-
pyrazolecarboxylate), it is used as a food coloring.[181-183].
21. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
375
(b) (a)
Fig.5
5-3) Applications in pesticide as in Fig.6
(a) Fipronil RS (5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-
(trifluoromethylsulfinyl)-1H-pyrazole-3-carbonitrile), it is a broad-use insecticide[145,184,185].
(b) Isopropylmethylpyrazolyl dimethylcarbamate (1-Isopropyl-3-methyl-1H-pyrazol-5-yl
dimethylcarbamate), it is used as pesticide[186].
(b)
Fig.6
CONCLUSION:
In this review, we showed that over the past decades pyrazoles have achieved an important
place in the arsenal of organic chemists involved in the construction of complex molecules and natural
products as well as biologically active molecules, Synthesis of Substituted or unsubstituted pyrazole
has employed a great interest either by classical methods or by using palladium catalysed
reactions.Finally, one can reasonably anticipate that future studies will provide new applications to the
preparations of complex molecules , particularly in the area of biologically active compounds.
ACKNOWLDGEMENT:
The authors would like to thank the Chemistry Department, Cairo University, for providing the
research facilities The author wishes to express his most sincere thanks and full gratitude to Prof. Dr.
Ahmad M. Farag and Mr Mahmoud H. Yousef.
22. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
376
REFERENCES:
1. T. Eicher, S. Hauptmann., The Chemistry of Heterocycles: Structure, Reactions, Syntheses,
and Applications. Wiley-VCH. ISBN 3-527-30720-6, 2nd
ed. 2003.
2. N. Fowden, Ridd and White., Proc. Chem. SOC.,1959, 131.
3. Noe and Fowden., Nature., 1959, 184, 4688, 69.
4. A.M. Farag, K.A.K. Ali, T.M.A. El-Debss, A.S. Mayhoub, A.E. Amr, N.A. Abdel-Hafez and
M.M. Abdulla., Eur. J. Med. Chem., 2010, 4, 55887-589.
5. A. M .Farag, A.S. Mayhoub, T.M.A. Eldebss, A.E. Amr, K.A.K. Ali, N. A. Abdel-Hafez and
M.M. Abdulla, Arch.Pharm. Chem Life., 2010, 343, 384-396.
6. K Nagarajan; V. P. J. Arya., Sci. Ind. Res., 1982, 41, 232.
7. V. P. Arya, R. S. Grewal, J. David, C. L. Kaul., Experientia., 1967, 23, 514.
8. W.T. Comer; A.W. Comell, "Burger's Medicinal chemistry, third edition, part ΙΙ" Ed.A.Burger,
wiley-Interscience, Newyork, 1970,1050.
9. V.P. Arya, R.S. Grewal, C.L. Kaul, S.P. Ghate, D.V. Mehta, T. George., J. Pharm. Sci., 1969,
58, 432.
10. R. Jakse, J. Svete, B. Stanovnik and A. Golobie., Tetrahedron., 2004, 60, 4601.
11. B. Stanovnik and J. Svete., Chem. Rev., 2004, 104, 2433.
12. E. Bejan, H. A. Haddou, J. C. Daran, G. G. A. Balavoine., Synthesis., 1996, 1012.
13. M. R. Shaaban, T. S. Saleh, A. M. Farag., Heterocycles., 2007, 71, 8.
14. R. M. Shaaban, T. S. Saleh, Faiz Osman, A. M. Farag., J. Heterocycl. Chem., 2007, 44, 177.
15. G. D. Leonard and S. M. Swain., J. Natl. Cancer Inst., 2004, 96, 906-920.
16. M. T. McDermott, F. D. Hofeldt, G. S. Kidd., South. Med. J., 1990,83, 1283-1285.
17. I. S. Fentiman, M. Caleffi, K. Brame, M. A.Chaudary and J. L Hayward., Lancet., 1986, 1,
287-288.
18. L. L. Amsterdam, Fertil Steril, 2005, 84, 300-304.
19. P. Merviel, Gynecol. Obstet. Fertil., 2006, 34, 66-39.
20. R. Homburg., Hum. Reprod., 2005, 20, 2043-2051.
21. P. Alexandersen, B. J. Riis, J. A. Stakkestad, P. D. Delmas, C. Christiansen., J. Clin.
Endocrinol. Metab., 2001, 86, 755-760.
22. W. Khovidhunkit and D. M. Shoback., Ann. Intern. Med., 1999,130, 431-439.
23. D. Clemett and C. M. Spencer., Drugs., 2000, 60, 379-411.
24. H. Yanyan, C. Michael, Y. Yate-Ching, C. Shiuan., Biochem. Pharmacol., 2008 ,75, 1161-1169.
23. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
377
25. N. D. Jaime, and William, (Eds.), Text Book of Organic Medicinal and Pharmaceutical
Chemistry, 10th edition, Lippincott-Raven Publishers, Philadelphia, 1998, p. 745.
26. S. Martino, J. A. Cauley, E. Barrett-Connor, T. J. Powles, J. Mershon, D. Disch, R. J. Secrest, S.
R. Cummings., J. Natl. Cancer Inst., 2004, 96, 1751-1761.
27. S. R. Cummings, S. Eckert, K. A. Krueger, D . Grady, T. J. Powles, J. A. Cauley, L .Norton,
T. Nickelsen, N. H. Bjarnason, M .Morrow, M. E. Lippman, D. Black, J. E. Glusman, A.
Costa, V. C. Jordan,. J.A.M.A., 1999, 281, 2189-2197.
28. P. Neven, I. Vergote., Lancet., 1998, 351, 155-157.
29. F. A. Aleem, M..Predanic., Lancet., 1995, 3461, 292-1293.
30. S. B. Gusberg., Cancer.,1990, 651, 463-1464.
31. L. R.Wiseman and K. L. Goa., Drugs.,1997, 541, 41-160.
32. K. Holli., Oncology., 1998, 12 (suppl 5), 23-27.
33. A. M. H. Brodie., Pharmacol. Ther., 1993, 60, 501-515.
34. W. L. Miller., Endocr. Rev., 1988, 9, 295 -318.
35. L. R. Wiseman, D. McTavish., Drugs., 1993, 45, 66-84.
36. K. Ellington, D. M. Faulds., Drugs., 2002, 62, 2483.
37. U. Gruntmanis, G. D. Braunstein., Curr. Opin. Investig. Drugs., 2001,2, 643-649.
38. P. E. Goss, E. P. Winer, I. F. Tannock, L. H. Schwartz., J. Clin. Oncol., 1999, 17, 52-63.
39. C. L. Harper-Wynne, N. P. Sacks, K. Shenton, F. A. MacNeill, P. Sauven, I. J. Laidlaw, Z.
Rayter, S. Miall, A. Howes, J. Salter, M. J. Hills, F. M. Lowe, R. A'Hern, N. Nasiri, D.
Doody, J. Iqbal, M .Dowsett., J. Clin. Oncol., 2002, 20, 1026-1035.
40. A. U. Buzdar, R. Smith, C .Vogel, P. Bonomi, A. M. Keller, G. Favis, M. Mulagha, J.
Cooper, Cancer., 1996, 77, 2503-2513.
41. E. W. Leschek, J. Jones, K. M Barnes, S. C. Hill, G. B. Jr. Cutler., J. Clin. Endocrinol. Metab.,
1999 ,84, 175-178.
42. D. Simpson, M. P. and C. M. Perry., Drugs., 2004, 64, 1213- 1230.
43. J. A. Garcia-Velasco, L. Moreno, A. Pacheco, A. Guillén, L .Duque, A .Requena, A. Pellicer,
Fertil. Steril., 2005, 84, 82-87.
44. T. Naruse, Y. Nishida, N. Ishiguro., Biomed. Pharmacother., 2007, 61, 338-346.
45. T. C. Dang, A. J. Dannenberg, K. Subbaramaiah, M. N. Dickler, M. M. Moasser, A. D. Seidman,
G. M. D’Andrea, M. Theodoulou, K. S. Panageas, L. Norton and C. A. Hudis., Clin. Cancer
Res., 2004, 10, 4062-4067.
46. A. Reardon, J. A. Quinn, J. Vredenburgh, J. N. Rich, S. Gururangan, M. Badruddoja, J. E.
24. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
378
Herndon, J. M. Dowell, A. H. Friedman, H. S. Friedman., Cancer., 2005, 103, 329-338.
47. F. W. Nugent, W. C. Mertens, S. Graziano, N .Levitan, R. Collea, A. Gajra, .J. Marshall, . J
McCann., Lung Cancer., 2005, 48, 267-273.
48. G. Gasparini, S. Meo, G. Comella, S. C. Stani, L. Mariani, T. Gamucci, A. Avallone, S. Lo
Vullo, G. Mansueto, P. Bonginelli, D. Gattuso, M. Gion., Cancer J., 2005, 11, 209-216.
49. C. X. Pan, P. Loehrer, D. Seitz, P. Helft, B. Juliar, R Ansari, W. Pletcher, J. Vinson, L. Cheng
and C. Sweeney., Oncology., 2005, 69, 63-70.
50. V. Ferrari, F. Valcamonico, V. Amoroso, E. Simoncini, L. Vassalli, P. Marpicati, G.
Rangoni, S. Grisanti, G. A. Tiberio, F. Nodari, C. Strina, G. Marini., Cancer Chemother.
Pharmacol., 2006, 57, 185-190.
51. I. Csiki, J. D. Morrow, A. Sandler, Y. Shyr, J. Oates, M. K. Williams, T. Dang, D. P.
Carbone, D. H. Johnson., Clin. Cancer Res., 2005, 11, 6634-6640.
52. L. W. Chow, C. W.Cheng, J. L. Wong and M. Toi., Biomed. Pharmacother., 59 (suppl 2),
2005, S302-305.
53. A. M. Farag, A. S. Mayhoub, S. E. Barakat, A. H .Bayomi., Bioorg. Med. Chem., 2008,16,
4569-4578.
54. A. M. Farag, A. S. Mayhoub, S. E .Barakat and A. H. Bayomi., Bioorg. Med. Chem., 2008,
16, 881-889.
55. A. S. Girgis, N. Mishriky, A. M. Farag, W. I. El-Eraky, H. Farag, Eur. J. Med. Chem., 2008, 43,
1818-1827.
56. M. R. Shaaban, T. S. Saleh, A. S. Mayhoub, A. Mansour, A. M. Farag., Bioorg. Med. Chem.,
2008, 16, 6344-6352.
57. A. M. Farag, Y. M. Elkholy, K. A. Ali., J. Heterocycl. Chem., 2008, 45, 279-283.
58. N. A. Kheder, Y. N. Mabkhot and A. M. Farag., Heterocycles., 2008, 75, 2937-2948.
59. N. A. Kheder, Y. N. Mabkhot and A. M. Farag., Heterocycles., 2008, 5, 887-897.
60. N. A . Kheder, Y. N .Mabkhot, A. M. Farag., Synth. Comm., 2008, 38, 3170-3182.
61. K. M. Dawood, A. M. Farag and N. A. Khedr., Arkivoc xv., 2008, 166-175.
62. K. M. Dawood, A. M. Farag, H. A. Abdel-Aziz., Heteroatom Chem., 2007, 18, 294.
63. M. R. Shaaban, T. S. Saleh, F. H. Osman and A. M. Farag., J. Heterocycl., Chem., 2007, 44,
177-181.
64. M. R. Shaaban, T. S. Saleh and A. M..Farag., Heterocycles., 2007, 71, 1765-1777.
65. A. M. Farag, K. M. Dawood and N. A. Khedr., J. Chem. Res., 2007, 472-474.
66. N. A. Hamdy, H. A. Abdel-Aziz, A. M. Farag, I. M. I. Fakhr., Monatsh. Chem., 2007, 138, 1001-
25. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
379
1010.
67. G. L. Beutner, J. T. Kuethe, M. M. Kim, N.Yasuda., J. Org. Chem., 2009, 74, 789.
68. J. Witherington, V. Bordas, S. L.Garland, D. M. B. Hickey, R. J. Ife, J. Liddle, M. Saunders, D.
G. Smith and R. W. Ward., Bioorg. Med. Chem. Lett., 2003, 13, 1577.
69. S. Ghosh, M. Karin., Cell., 2002, 109, S91.
70. M. Peifer, P. Polakis., Science., 2000, 287, 1606.
71. R. Bhatt, Y. Xue, S.Berg, S. Hellberg, M. Ormo, Y. Nilsson, A. C. Radesáter, E. Jerning, P. O.
Markgren, T. Borgegàrd, M. Nylof, A. Gimenez-Cassina, F. Hernández, J. L. Lucas, J. Diaz-
Nido, J. Avila., J. Biol. Chem., 2003, 278, 45937.
72. M. Malumbres, P. Pevarello, M. Barbacid and J. R. Bischoff., Trends Pharmacol. Sci., 2008,
29, 16.
73. R. N. Misra, H. Xiao, D. B. Rawlins, W. Shan, K. A. Kellar, J. G. Mulheron, J. S. Sack, J. S.
Tokarski, S. D. Kimball, K. R. Webster, Bioorg. Med. Chem. Lett., 2003, 13, 2405.
74. A. Schmidt, A. Dreger., Curr. Org. Chem., 2011, 15, 1423-1463
75. A. Hauhan, P.K. Sharma, N. Kaushik., Int. J. Chem.Tech. Res., 2011,3, 11-17.
76. P.C. Lv, H.Q. Li, J. Sun, H.L. Zhou., Bioorg. Med. Chem., 2010, 18, 4606-4614.
77. R. Lin, G.Chiu, Y. Yu, P.J. Connolly, S. Li, Y. Lu , M. Adams, A.R. Fuentes-Pesquera, E.L.
Stuart, L.M. Greenberger., Bioorg. Med. Chem. Lett., 2007, 17, 4557-4561.
78. Al-Saadi, M. S. M., Saudi Pharm. J., 2008, 16, 135-145.
79. M. Bonesi, M.R. Loizzo, G. Statti, S. Michel, F. Tillequin, F. Menichini., Bioorg.Med. Chem.
Lett., 2010, 20, 1990-1993.
80. S. Sahu, M. Banerjee, A. Samantray, C. Behera, M. Azam., Trop. J. Pharm. Res., 2008, 7,
961-968.
81. R.V. Ragavan, V. Vijayakumar, N.S. Kumaric., Eur. J. Med. Chem., 2010, 45, 1173-1180.
82. W. Krohs., Chem. Ber., 1955, 88, 866–874.
83. M.E. Wolff., Burger’s Medicinal Chemistry, vol. I, Wiley, NewYork, 3rd edn., 1970, col. I, p.
964.
84. G. Mazzone, G. Puglisi, A. Corsaro, A. Panico, F. Bonina, M. Amico-Roxas, A.Caruso, S.
Trombadone., Eur. J. Med. Chem. Chim. Ther., 1986, 21(4), 277–284.
85. A. Oznur, N. Cesur., Acta Pharm. Turc., 1987, 29 (2), 51–64.
86. A. Gursoy and S. Demirayak., Acta Pharm. Turc., 1988, 30, 115–128.
87. S. Demirayak , M.I. Cingi, K. Erol., J. Health Sci., 1990, 2, 59–62 .
88. A. Gursoy, S. Demirayak, G. Capan, K. Erol, K. Vural., Eur. J. Chem., 2000, 35, 359–364.
26. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
380
89. G. Turan-Zitouni, M. Sıvacı, F.S. Kılıc, K. Erol., Eur. J. Med. Chem., 2001, 36, 685–689.
90. A. Bekhit and H.T.Y. Fahmy., Arch. Pharm. Pharm. Med. Chem., 2003, 2, 111–118.
91. A.A. Bekhit and T. Abdel-Azeim., Bioorg. Med. Chem., 2004, 12, 1935–1945.
92. E. Banoglu, C. Akoglu, S. Unlu, E. Kupeli, E. Yesilada, M.F. Sahin., Arch.
Pharm. Med. Chem., 2004, 337,
93. S.A.M. El-Hawash, E.A.M. Badawey, I.M. El-Ashmawy., Eur. J. Med. Chem., 2006, 41,
155–165.
94. O. Rosati, M. Curini, M.C. Marcotullio, A. Macchiarulo, M. Perfumi, L. Mattioli, F.
Rismondo, G. Cravotto., Bioorg. Med. Chem., 2007, 15, 3463–3473.
95. G. Szabo, J. Fischer, A. Kis-Varga, K. Gyires., J. Med. Chem., 2008, 51, 142–147
96. N. Benaamane, B. Nedjar-Kolli, Y. Bentarzi, L. Hammal, A. Geronikaki, P. Eleftheriou, A.
Lagunin., Bioorg. Med. Chem., 2008, 6, 3059–3066.
97. H. Foks, D. Pancechowska-Ksepko, A. Kedzia, Z. Zwolska, M. Janowiec,
98. E. Augustynowicz-Kopec., Il Farmaco., 2005, 60, 513–517.
99. A.M. Gilbert, A. Failli, J. Shumsky, Y. Yang, A. Severin, G. Singh, W. Hu,
100. D. Keeney, P.J. Petersen, A.H. Katz., J. Med. Chem., 2006, 49, 6027–6036.
101. A.H. Shamroukh, M.E.A. Zaki, E.M.H. Morsy, F.M. Abdel-Motti,F.M.E. Abdel-
Megeid., Arch. Pharm. Chem. Life Sci., 2007, 340, 345–35
102. O. Prakash, R. Kumar, V. Parkash., Eur. J. Med. Chem., 2008, 43, 435–440.
103. S. Kuettel, A. Zambon, M. Kaiser, R. Brun, L. Scapozza, R. Perozzo., J. Med.Chem., 2007,
50, 5833–5839.
104. R.Z. Yan, X.Y. Liu, W.F. Xu, C. Pannecouque, M. Witvrouw, De Clercq., E. Arch. Pharm.
Res., 2006, 29, 957–962.
105. A.F. Rostom, M.A. Shalaby, M.A. El-Demellawy., Eur. J. Med. Chem. 2003, 38, 959–974
106. P. Diana, A. Carbone, P. Barraja, A. Martorana, O. Gia, L. DallaVia.,G. Cirrincione.,
Bioorg. Med. Chem. Lett., 2007, 17, 6134–6137.
107. A.M. Farag, A.S. Mayhoub, S.E. Barakat, A. H. Bayomi, Bioorg. Med. Chem., 2008, 16, 881.
108. J. Elguero, P. Goya, N. Jagerovic, A.M.S Silva, Italian Society of Chemistry., Roma, 2002,
6, 167-203.
109. Q. Han, C.H. Chang, R. Li, Y. Ru, P.K. Jadhav, P.Y.S. Lam., J. Med. Chem., 1998, 41, 2019.
(A) A. Weber, A. Casini, A. Heine, D. Kuhn, C.T. Supura., A.Scozzafava, G. Klebe., J.
Med. Chem., 2004, 47, 550. [b] S.F. Vasilevsky, S.V. Klyatskaya, Elguero., J.
27. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
381
Tetrahedron., 2004, 60, 6685.D.R. Sliskovic, B.D. Roth, M.W. Wilson, M.L. Hoefle,
R.S. Newton., J. Med. Chem., 1990, 33, 31.
(B) S. Manfredini, R. Bazzanini, P.G. Baraldi, D. Simone, S. Vertuani, A. Pani,E. Pinna, F .Scintu,
D. Lichino, P. La Colla., Bioorg. Med. Chem. Lett., 1996, 6, 1279.
110. S.R. Stauffer, Y. Huang, C.J. Coletta, R. Tesdesco, J. Katzenellenbogen., J. Bioorg. Med.
Chem. Lett., 2001, 9, 141.
111. M.I. Rodríguez-Franco, I. Dorrosonro, A. Martínez., Synthesis., 2001, 11, 1711.
112. A. Schmidt, A. Dreger., Curr. Org. Chem., 2011,15(9), 1423–1463.
113. L. Knorr., Ber. Dtsch. Chem. Ges., 1883, 16, 2597–2599.
114. S. William Johnson and J. Robert J. Highet., Org. Synth. Coll., 1963, 4, 351
115. Pyrazol aus Acetylen and Diazomethan H. V. Pechmann Berichte der deutschen chemischen
Gesellschaft., 1898, 31 (3), 2950–51.
116. Mario Gyuris, Laszlo G. Puskas, A. Gabor K. Tothb and Ivan Kanizsai., Org. Biomol. Chem.,
2013, 11, 6320-632.
117. F. Gabrera Escribano, M. P. Derri Alcantara and A. Gomez-Senchez., Tetrahedron Letters.,
1988, 29(46), 6001-6004.
118. L.L. Wu, Y.C. Ge, T. He, L. Zhang, X.-L. Fu, H.-Y. Fu, H. Chen, R.-X. Li., Synthesis.,
2012, 1577-1583.
119. S. T. Heller and S. R. Natarajan., Org. Lett., 2006, 8, 2675-2678.
120. F. Gosselin, P. D. OShea, R. A. Webster, R. A. Reamer, R. D. Tillyer, E. J. J. Grabowski.,
Synlett., 2006, 3267-3270.
121. M. S. M. Ahmed, K. Kobayashi and A. Mori., Org. Lett., 2005, 7, 4487-4489.
122. B. S. Gerstenberger, M. R. Rauckhorst and J. T. Starr., Org. Lett., 2009, 11, 2097-2100.
123. M. S. M. Ahmed, K. Kobayashi and A. Mori, Org. Lett., 2005, 7, 4487-4489.
124. X. Deng, N. S. Mani., Org. Lett., 2008, 10, 1307-1310.
125. X. Deng and N. S. Mani, J. Org. Chem., 2008, 73, 2412-2415.
126. X. Deng and N. S. Mani., Org. Lett., 2006, 8, 3505-3508.
127. J.Hu, S.Chen,Y.Sun, J.Yang, Y.Rao., Org. Lett., 2012, 14, 5030-5033.
128. R . Martin, M. R. Rivero, S. L. Buchwald, Angew. Chem. Int. Ed., 2006, 45, 7079-7082.
129. O. Jackowski, T. Lecourt, L. Micouin., Org. Lett., 2011, 13, 5664-5667.
130. J. P. Waldo, S. Mehta, R. C. Larock., J. Org. Chem., 2008, 73, 6666-6670.
131. D. J. Babinski, H. R. Aguilar, R. Still, D. E. Frantz, J. Org. Chem., 2011, 76, 5915-5923.
28. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
382
132. F. A. Rosa, P. Machado, P. S. Vargas, H. G. Bonacorso, N. Zanatta, M. A. P. Martins, Synlett.,
2008, 1673-1678.
133. C. Ma, Y. Li, P. Wen, R. Yan, Z. Ren, G. Huang., Synlett., 2011, 1321-1323.
134. Y. Hari, S. Tsuchida, R. Sone, T. Aoyama., Synthesis., 2007, 3371-3375.
135. N. Nakamichi, Y. Kawashita, M. Hayashi., Synthesis., 2004, 1015-1020.
136. X. Xiong, Y. Jiang, D. Ma, Org. Lett., 2012, 14, 2552-2555.
137. B. C. Wray, J. P. Stambuli., Org. Lett., 2010, 12, 4576-4579.
138. C. Wu, Y. Fang, R. C. Larock, F. Shi., Org. Lett., 2010, 12, 2171-2173.
139. P. Li, C. Wu, J. Zhao, D. C. Rogness, F. Shi., J. Org. Chem., 2012, 77, 3127-3133.
140. P. Li, J. Zhao, C. Wu, R. C. Larock, F. Shi, Org. Lett., 2011, 13, 3340-3343.
141. Z. Liu, F. Shi, P. D. G. Martinze, C. Raminelli, R. C. Larock., J. Org. Chem., 2008, 73, 219-
226.
142. M. R. Kumar, A. Park, N. Park, S. Lee., Org. Lett., 2011, 13, 3542-3545.
143. V. Lefebvre, T. Cailly, F. Fabis and S. Rault, J. Org. Chem., 2010, 75, 2730-2732.
144. Hongjian Song , Yuxiu Liu, Lixia Xiong , Yongqiang Li, Na Yang , and Qingmin Wang J.
Agric. Food Chem., 2013, 61 (37), 8730–8736.
145. Majid M.Heravi, Mina Saeedi Yahya S. Beheshtiha, Hossein A. OskooieMo., Divers.
2011,15(1) , 239-243.
146. M. R. Shaaban, T.M.A. Eldebss, A .F.Darweesh and A.M.Farag., J. of Chemical Research.,
2010, 8 -11.
147. M. R. Shaaban, T.M.A. Eldebss, A .F. Darweesh and A.M.Farag., J. Heterocyclic Chem. 2008,
45,1739.
148. Tamer S. Saleh, Taha M.A. Eldebss and Hassan M. Albishri., Ultrasonics Sonochemistry.,
2012, 19, 49–55.
149. R. Levine and J.K.Sneed., J. Am. Chem. Soc., 1951, 73, 5614.
150. L. Fabbrini., Farmaco Ed. Sci., 1954, 9, 603.
151. M. Ferles, S. Kafka and A. Silkhankova., Coll. Czech. Chem. Commun., 1981, 46, 1167.
152. M. Ferles, R. Liboska and P. Trska., Coll. Czech. Chem. Commun., 1990, 55, 1228.
153. A. F. Rostom, Ibrahim M. El-Ashmawy, A. Heba, Abd El Razik, H. Mona, H. Badr, M.A.
Hayam., Ashour Bioorganic & Medicinal Chemistry., 2009, 17(2), 882–895.
154. M.P.Claudio M. P. Pereira Frank H. Quina, Filipe A. N. Silva, Daniel J. Emmerich, and
Amilcar Machulek Jr. Mini-Reviews in Organic Chemistry., 2008, 5, 331-335.
29. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
383
155. Li Ming, Wen Lirong, Wang Xiao, Yao ChangCheng, Fu Weijun, Zhao Guilong, Hu
Fangzhong & Yang Huazheng., Indian Journal of Chemistry.,2006, 45B, 483-488.
156. V.B. Birman and X.T. Jiang., Organic Letters., 2004, 6, 2369-2371.
157. Rita D Brandao, Jurgen Veeck, Koen K Van de Vijver, Patrick Lindsey, Bart de
Vries,Catharina HMJ van Elssen, Marinus J Blok, Kristien Keymeulen, Torik Ayoubi, Hubert
JM Smeets,Vivianne C Tjan-Heijnen and Pierre S Hupperets., Breast Cancer Research., 2013,
15, R29.
158. D. Mukherjee,S.E.Nissen,E.J.Topol.,JAMA.,2001,286(8),954-959.
159. J.K. Jenkins, P.J. Seligman., (2005-04-06). "Analysis and recommendations for Agency action
regarding non-steroidal anti-inflammatory drugs and cardiovascular risk [decision
memorandum]" (PDF). FDA Center for Drug Evaluation and Research
160. S. Haj-Dahmane, T. Jolas, A.M. Laporte., et al. European Journal of Pharmacology., 1994,
255 (1-3), 185–96.
161. Billy R. Martin, Raj K. Razdan, Anu Mahadevan., Pyrazole cannabinoid agonist and
antagonists. US Patent 6509367, filed Sep 22, 2001, issued Jan 21, 2003.
162. J.Y. Shim, W.J. Welsh, E. Cartier, J.L. Edwards, A.C. Howlett., Journal of Medicinal
Chemistry., 2002,45(7),1447-59.
163. M.E Francisco, H.H.Seltzman, A.F. Gilliam, R.A. Mitchell, S.L. Rider, R.G. Pertwee,
L.A.Stevenson, B.F. Thomas., Journal of Medicinal Chemistry., 2002, 45(13), 2708-19.
164. T.M. Fong and S.B Heymsfield., Int J Obes (Lond)., 2009, 33 (9), 947–55.
165. D.P. Hurst, D.L. Lynch, J. Barnett-Norris, S.M. Hyatt, H.H.Seltzman., M. Zhong,Z.H. Song, J.
Nie., Molecular Pharmacology.,2008,62(6),1274–87.
166. D. Hurst, U. Umejiego, D. Lynch, H. Seltzman, S. Hyatt, M. Roche, S. McAllister, D.
Fleischer., et al., Journal of Medical Chemistry.,2006,49(20),5969–87.
167. W. Graham Thwaite Colin, C. Bower, Anne M. Hately., Danuta Swist-Swirski., 1996, 20(4),
177-191.
168. R. Lan, Q. Liu, P. Fan, et al. J Med Chem.,1999, 42, 769-776.
169. L.D.Wruble, A.J. Cummins, J. Goldenberg, H. Schapiro., Digestive Diseases and Sciences.,
1967, 12(11), 1087–1090.
170. G. Stacher and Doris Starker., Journal List Gut.1974, 15(2), 974.
171. A. Brenchat, L.Romero, M. García, M. Pujol, J. Burgueno, A. Torrens, M. Hamon, J.M.
Baeyens, H. Buschmann, D. Zamanillo, J.M. Vela.,Pain., 2009,141(3), 239–47.
172. A. Brenchat, M. Ejarque, D. Zamanillo, J.M. Vela, L. Romero., Journal of Pharmacological
Sciences.,2007, 116 (4), 388–91.
173. D.C. Argentieri, D.M. Ritchie, M.P. Ferro, T. Kirchner, M.P. Wachter, D.W. Anderson, M.E.
Rosenthale, R.J. Capetola., J Pharmacol Exp Ther., 1994, 271(3), 1399-408
174. http://www.ah.novartis.com/products/en/prac-tic_dog.shtml.
30. Asian Journal of Biochemical and Pharmaceutical Research Issue 3 (Vol. 4) 2014
CODEN(USA) : AJBPAD
384
175. D.L. Millis, J.P. Weigel, T. Moyers, F.C. Buonomo., Vet Ther., 2002,3(4), 453-64.
176. European Public Assessment Report (EPAR): Trocoxil, European Medicines Agency
177. S.R.Cox, S.P. Lesman, J.F. Boucher, M.J. Krautmann, B.D. Hummel, M. Savides, S. Marsh.,
A. Fielder., et al., Journal of Veterinary Pharmacology and Therapeutics., 2010, 33(5),461–70.
178. I.F. Gaunt, F.M.B. Carpanini, Ida S. Kiss,P. Grasso., Food and Cosmetics Toxicology., 1971,
9(3), 343–353.
179. Food Standards Australia New Zealand. "Food Additives- Numerical List". Retrieved 2
December., 2009.
180. J .Current EU approved additives and their E Numbers", Food Standards Agency website,
retrieved 15 Dec 201.1
181. MS Bhatia., Medical Journal Year., 1996, 9(8), 285-286.
182. V. Raymond-Delpech, K. Matsuda, B.M. Sattelle, J.J. Rauh, D.B. Sattelle., Invert Neurosci.,
2005, 1-15
183. Ana Csuma, Cornelia Pirlog Medicamentul Veterinar / Veterinary Drug., 5(2), 2011.
184. Isopropylmethylpyrazolyl dimethylcarbamate at cameochemicals.noaa.gov.
185. Jia-Jia Liu, Juan Sun, Yun-Bin Fang, Yong-An Yang, Rui-Hua Jiao and Hai-Liang Zhu
Org. Biomol. Chem., 2014, 12, 998-1008.
186. S. K. Mishraa, P. Majumdara, R. K. Beheraa & A. K.r Beheraa, Synthetic Communications:
An International Journal for Rapid Communication of Synthetic Organic Chemistry, 2014 , 44,
(1), 32-41.
187. K.O. Mohammed and Y. M. Nissan., Chemical Biology & Drug Design., 2014, 84(4), 473–
488,
188. J. Jaunzems , M.X. Braun, S. F. GmbH, H. B. Allee., 20, 30
189. Hannover., Germany Org. Process Res. Dev., 2014, 18(8), 1055–1059.
190. Jia-Jia Liu, Juan Sun, Yun-Bin Fang, Yong-An Yang, Rui-Hua Jiao and Hai-Liang Zhu
Org. Biomol. Chem., 2014, 12, 998-1008.
191. M. Su, M. Tomas-Gamasaa and T. Carell., Chemical Science., 2014, S1, 001.
192. M. A Abdelgawad, K. RA Abdellatif and O. M. Ahmed., Medicinal Chemistry., 2014, S1,001.
*Correspondence Author: Taha M.A Eldebss,, Department of Chemistry, Faculty of Science,
University of Cairo, Giza 12613, Egypt
View publication stats